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Four experiments were conducted to characterize the microbiome of the piglet
and observe effects of diet on growth performance and immunity. In Exp. 1, 96 nursery
piglets were fed varying carbohydrate sources and in Exp. 2, 64 piglets were fed a soy
protein concentrate or soybean meal as-is or supplemented with an isoflavone
concentrate. Body and feeder weights were measured for growth performance estimation.
Luminal contents and scrapings were isolated for microbial composition analysis. Fecal
and blood samples were extracted in Exp. 2 for microbiome and immunity analysis. Diets
did not affect growth performance (P > 0.10); however, Exp. 1 piglets had greater
average daily feed intake of the experimental diets in phase 1 (P < 0.05). There were no
differences in microbiome composition among diets (P > 0.10), but a trend over time (P =
0.11). Differences in microbial composition between sampling locations were shown in
Exp. 1 and 2 (P < 0.01). In Exp. 2, diet and time altered microbial diversity (P < 0.001).
IL-8 was not influenced by diet, (P > 0.10) but increased over time (P < 0.001). In Exp. 3,
IPEC-J2 cells were treated with varying doses of the isoflavone genistein,
lipopolysaccharides (LPS), or polyinosinic:polycytidylic acid (poly I:C). In Exp. 4, cells
were treated with the isoflavones genistin, genistein, daidzin, or daidzein, and poly I:C or

diclofenac sodium salt. Media from the basolateral membrane or apical membrane sides
were used for IL-8 ELISA and TEER was measured to estimate epithelial integrity. In
Exp. 3, LPS showed greatest electrical resistance (P = 0.014) unlike Exp. 4 that showed
no differences in TEER for time or treatment (P > 0.10) In Exp. 3 and 4, IL-8
concentration increased over time (P < 0.01) and was greater in the BLM (P < 0.05). In
Exp. 4, IL-8 production from the poly I:C treatment was greater than the other treatments
(P = 0.0186). In conclusion, characterization of the microbiome is influenced by diet,
time and sampling location. Immune parameters were not different in the in vitro or in
vivo trial with isoflavones and diet did not affect growth performance.
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Chapter 1: Literature Review

2
INTRODUCTION
Nutritional intervention is becoming a staple in the livestock industry with the
new implementation of the Veterinary Feed Directive prohibiting the use of nonprescribed antibiotics in feed and leaving producers wondering how they might protect
their livestock from disease. Gut health improvement has recently become a popular topic
for preventing the spread of pathogens and is necessary as disease is the greatest
contributor to economic losses in the livestock industry with the U.S. exporting $6.32
billion in pork in 2016 alone (Schulz et al., 2016) and a concern for mortality in humans.
Researchers and producers are striving to discover compounds found in common feed
sources that could be isolated and supplemented to positively influence the
gastrointestinal microbiota while minimizing the use of antibiotics. The integration of gut
bacteria colonization and maturation of the immune system has been widely accepted as
valuable in managing and preventing disease by using alternative diet ingredients to
manipulate microbial composition and influence immune parameters as a less invasive
method than antibiotic use (Filippis et al., 2018). Antibiotics have also been found to
lower the immune system by deteriorating both beneficial and detrimental microbes,
creating the need for other medicinal factors that could be implemented while leaving the
microbiome intact. If the microbiome is able to sustain a healthy environment and
enhance immune responses through nutritional intervention, the slower the onset of
disease could be, providing researchers and producers more time to diagnose and treat
disease before a devastating impact ensues.
Immunity is represented by the presence of microbes that are able to fend off
invading pathogens and can be influenced by gut health as well as extrinsic and intrinsic
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factors of the immune system. This can be measured both in vivo and in vitro by
quantifying cytokine levels, T cell functionality, monocytes, and others. Researchers are
interested in conducting experiments where adequate data are measured with the least
cost and time, creating a demand for cell culture trials, including a cell line cultured from
the jejunum of an unsuckled neonatal piglet. To determine if an experiment is worth the
time, money, and effort put into a live animal trial, it’s reassuring to first have a response
in an in vivo trial.
The objective of this chapter is to review the development and composition of the
microbiome, the immune parameters that may be studied, measured, or influenced, and
discuss an epithelial cell line used in nutritional studies.

THE GUT MICROBIOME
Background
The gut microbiome consists of a dynamic microbial population that influences
the phenotype of a mammal and represents the community of intestinal microorganisms.
It historically was referred to as microflora, until non-bacterial elements such as archaea,
fungi, and viruses that also regularly inhabit the gut were accounted for (Quigley et al.,
2013). While it maintains a symbiotic relationship with the host, an imbalance of
microbes, such as during times of stress, causes susceptibility to disease (Rea et al.,
2016). Antibiotics have been used to combat symptoms; however, there has been concern
that anti-microbial resistant bacteria has developed and resulted in a demand for
decreased use of antibiotics by the public (Dibner et al., 2005), increasing the need for
nutritional intervention. Diet of the host and microbes is critical to the digestion and
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absorption of nutrients, contributing to the integrity of the intestinal epithelial layer that
prevents pathogens from invading the host’s gastrointestinal tract (Kyle et al., 2017).
Diversity follows patterns of community structure, but the microbiome is a unique
influencer of gut health that can be managed through diet and environment.

Development
The development of the microbiome depends on environment and influences
mammalian health and prevention of disease. The diversity of microbes, especially in
young mammals, is crucial to avert autoimmune and inflammatory diseases that may
result later in life if the microbiome is not properly constructed. One study has shown that
growth and change in composition of gut microbes starts before the mammal is born by
contribution of maternal microbiota to the fetus as the fetus initially maintains a sterile
gastrointestinal tract (GIT); however, this could have been due to contamination of the
amniotic fluid (Walker et al., 2017). As maturation occurs, the mammalian gut becomes
home to over 100 trillion bacterial cells (Holman et al., 2017) and the majority of
microbial development takes place in the first 2-5 years of life. The microbiome is
influenced by the amount of exposure to a variety of microbes, pathogens, and antibiotics
in everyday scenarios such as delivery method, environment, lifestyle, genetics, and diet
(Rodríguez et al., 2015).
Most studies have shown that the GIT is first inoculated when the infant is
exposed to maternal vaginal and fecal bacteria during birth. Mammals that experience
assisted delivery that are not allowed as much exposure to diverse bacterial species have
been shown to struggle with optimal colonization for the first few years of life (Jakobsson
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et al., 2013). The first bacteria to populate the GIT in an anaerobic environment include
Proteobacteria, Prevotella, and Actinobacteria, but the GIT changes to include higher
abundances of Bacteriodetes and Firmicutes as age sets in (Rodríguez et al., 2015).
Germ-free animals show the importance of regular development of gut barrier microbiota
and their functions, as they suffer from compromised immune systems and inhibited
progress in the epithelium, vasculature, neuromuscular apparatus, and gut endocrine
system when not exposed to typical microbial environments (Quigley et al., 2013). In the
swine GIT, Prevotella is the most abundant genus in the adult, but is also commonly
found in high quantities in humans and some ruminant animals. Colonization is still
predisposed to change as a result of diet whether, the infant consumes bacteria naturally
found in milk or if a formula is consumed. Over 700 species of bacteria are found in milk
(Cabrera-Rubio et al., 2012) which stimulates colonization of Bifidobacterium that’s
originally introduced to the microbiome during birth. Infants have altered microbial
composition compared to adults that gradually becomes similar as nutritional needs
change, reflecting a necessity for different species. As solid food is introduced into the
diet, butyrate producers such as Bacteroides and Clostridium become more prominent
throughout adulthood (Neu et al., 2011). Microbiome studies depict similarity of
microbial composition in all species, contributing to evidence that these studies are
interchangeable.

Diversity
Studies focus on alpha- and beta-diversity of the microbiome that measure the
presence of bacteria within individuals and the variation between individuals,
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respectively. Diversity indices allow researchers to depict the differences in a community
and point out rarity while quantifying diversity. As the microbiome is an ever-changing
environment, diversity is highly variable over time and across human populations;
however, there have been attempts to establish a core microbiome (Holman et al., 2017).
The malleability of the microbial composition is crucial, as a more diverse setting will
optimize colonization resistance where the native microbes prevent the invasion of
pathogens and even beneficial microbes. A lower presence of species has been associated
with dysbiosis in the gut and is associated with autoimmune diseases, cardiometabolic
disease, and obesity (Sacks et al., 2006). In a rapidly fluctuating setting, diversity of
microorganisms aids in maintaining regular functionality when environmental challenges
arise and is most influenced during the early stages of life. Population abundance of
microbes in the gut has been linked to metabolism, homeostasis, and immune
development and can be altered by close contact with other individuals or material
ingested (Maslowski et al., 2011). There is a need for more studies that characterize the
microbial patterns in the environment to further understand the influences on the structure
of the microbiome and how it becomes established for some microbes compared to
others. In diet, it has been shown that omnivores have a higher diversity when compared
to vegetarians, proposing that microbiota composition varies with diet (Maslowski et al.,
2011). Understanding that difference in locations and cultures result in different eating
habits and sources, microbial diversity varies across the world, even within the same
species as the African microbiome diversity is greater than Western cultures due to
further age and exposure (Conlon et al., 2014). Once established in the GIT, microbes
become more stable as they find their niche and stake claim on the space and nutrients
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needed for survival. A niche has been described as the complex description of how an
organism uses its environment depending upon the metabolic properties of the organism
and are constantly adapting to fill every ecological niche on the planet by fighting for
resources that determine survival and genetic persistence (Bauer et al., 2018). Events that
occur as a part of life, such as surgery or infections, can have detrimental impacts on
diversity as the use of antibiotics can cause the deterioration of beneficial microbial
populations while attempting to rid of the harmful organisms. The presence of certain
macronutrients will influence microbiota as the more nutrients to thrive off of, the more
competitive a species can become and colonize in the gut more efficiently. A study using
high-fat diets saw an increase in Rikenellaceae in turn for a decrease in Ruminococcaeae,
a prominent carbohydrate fermenter (Jakobsson et al., 2013). The availability of nutrients
creates an advantage for some species by competition in the GIT.

Relationship with the host
The relationship between the microbes that inhabit the gut and their host is highly
complex and health and disease of the host depend on microbial diversity. The
development of the GIT microbiota occurs in parallel to the growth, maturation, and
sprouting of neurons in the young brain (Rea et al., 2016). The microbiota-gut-brain axis
is a matrix of tissues that communicate to regulate various immune functions based on
microbial composition in the gut (Rea et al., 2016). The microbes communicate with the
host by influencing the enteric, sympathetic, and parasympathetic nervous systems to
activate neuroimmune components of the central nervous system. This close relationship
is mutually beneficial and contributes to the host’s energy regulation, gut barrier function,
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pathogen protection, and overall immune system function (Bengmark et al., 2013). The
human GIT microbiota alone upregulate nearly 2 million genes (Quigley et al., 2013).
Communication between commensal bacteria and the host induce regulatory cells, such
as T cells, that consequently produce anti-inflammatory cytokines for the animal (Conlon
et al., 2014).

Diet in microbes
Microorganisms are most influenced by macronutrients in the diet and GIT.
Depending on the presence of starches, fibers, proteins, and other dietary components
ingested, variation in individual microbial composition can be as unique as a fingerprint.

Carbohydrates
Carbohydrates are the key carbon and energy sources for microbes, metabolized
into short-chained fatty acids (SCFA) during fermentation (Conlon et al., 2014). Among
these SCFA is butyrate that is synthesized by microbes and serves as the principal source
of metabolic energy for cells located in the colon, or colonocytes. Carbohydrate digestion
begins in the mouth with enzymatic degradation by salivary amylase. After carbohydrates
pass through the esophagus into the stomach and enzymes are inactivated in the acidic
environment, a majority of the carbohydrates enter the small intestine. The mammalian
genome does not encode a large enough quantity of the enzymes required for
carbohydrate degradation, signifying the need for microbial fermentation using
carbohydrate active enzymes, or CAZymes (Flint et al., 2012). The prominent families of
Bacteroidetes, Actinobacteria, and Firmicutes possess the greatest quantity of CAZymes
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that degrade specific polysaccharides, depending upon their location in the GIT, as shown
in Table 1. Firmicutes and Bacteroidetes pathways are specific to fructan, lactose, and
starch metabolism and the CAZymes increase degradation of these carbohydrates in the
extracellular space, cytoplasm, and periplasmic space (Wang et al., 2019). The
microbiota show flexibility in that they’re able to transition between metabolizing diet
and host-derived carbohydrates, proving they’re not limited to metabolizing only waste
after physical and chemical degradation by the host. The structure of the carbohydrates
influences microbial composition because the bacterial community depends on the
availability of simple carbohydrates (Zoetendal et al., 2012). If non-digestible
carbohydrates are excluded from the diet, the microbiota will utilize endogenous energy
sources, including mucin that lines the intestine, which results in the degradation of the
membrane that serves as epithelial cell protection and increases risk for pathogen
invasion. While simple starches are readily utilized in the small intestine, resistant
starches are the largest sources of energy for microbes provided by diet, depending upon
the degree of processing of the carbohydrate source before the feed is ingested. The host
and microbiota both depend upon carbohydrates for energy to use in cellular processes
and for growth by the degradation of complex carbohydrates in cell walls and starches.

Protein
Bacteria and the host provide proteases and peptidases to hydrolyze proteins into
peptides and amino acids in the small intestine. These metabolites can be further utilized
by the host and the microbes, feeding off of one another. Clostridium, Lactobacillis,
Streptococcus, and Proteobacteria are amongst the leading fermenters of amino acids in
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the small intestine (Cho et al., 2007). Clostridia and Peptostreptococci manage the amino
acids that reach the large intestine; however, if too much protein fermentation occurs
when these residuals reach the colon, cytotoxic metabolites such as ammonia and
carcinogens can be detrimental to the microbial population if the nitrogen isn’t utilized by
the microbes (Conlon et al., 2014). The process of degradation in the small intestine is by
bacteria containing highly active peptidases is extremely efficient; however, not all
metabolites are utilized in this location and will either enter the bloodstream or continue
into the colon to be used by colonocytes. The amino acids utilized undergo de novo
synthesis to produce other amino acids, such as lysine, particularly in the large intestine
where microbes harbor a voluminous number of genes used in essential amino acid
biosynthesis (Sacks et al., 2006). Amino acids may also be used by anaerobic bacteria as
a precursor for the SCFA acetate and butyrate. Another SCFA, propionate, is exclusive
to synthesis from threonine, providing alternative energy sources to carbohydrates. This
is a significant consideration for trials exploring carbohydrate sources, as the protein
content must be similar.

Lipids
The digestion of lipids by microbiota is less clear as a majority of studies assumed
that fat was digested mainly in the small intestine. It has been shown that microbes only
influence certain aspects of lipid metabolism, including body mass index as well as
composition of triglycerides and high-density lipoproteins. Most fats are regulated by bile
acids present in the small intestine, and facultative and anaerobic bacteria produce
secondary bile acids that subsequently impact glucose metabolism once immersed in the
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bloodstream (Ghazalpour et al., 2016). These bacteria also participate in complex
carbohydrate fermentation, influencing the production of SCFA that influence immunity
and have hormonal effects in the host. The microbiota also produce fatty acid oxidation
precursors that enhance lipid metabolism, such as trimethylamine N-oxide (Ghazalpour et
al., 2016). The role of microbiota in lipid digestion is less clear than other
macromolecules and further experimentation is needed to determine the effect that GIT
microbes have on fat and vice versa.

Gut health in relationship to disease
Understanding that providing a complete diet to not only the host, but the
microorganisms in the gut influences immune functions, it’s apparent that the welfare of
both the microbiome and the host depends on optimal gut health. Microbes regulate
stress, the disturbance of the homeostasis of an organism, preventing neuroinflammation
that has been attributed to psychiatric disorders such as anxiety and depression (Koonin
et al., 2012). During times of stress, a loss in lactic acid producing bacteria is observed,
which results in an increase of pH. This results in enhanced disease susceptibility as a
low pH is crucial in the gut to maintain a bacteriocidal environment that invading
pathogens cannot normally survive in. If disease is on setting, the host and microbiome
may also develop a negative relationship where the host cannot recognize the normal
flora and an inflammatory response ensues that damages the epithelial lining and results
in bacteria entering the intestinal wall, submucosa, and circulation (Quigley et al., 2013).
Maintaining positively progressing gut health can prevent pathogen invasion by
regulating normal bodily functions and maintaining homeostasis by use of the beneficial
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metabolites supplemented by microorganisms in the GIT. When antibiotics are
introduced to the microorganisms, they eliminate not only the problematic bacteria, but
the beneficial microbes as well, resulting in a clean slate in the GIT for different
pathogens to enter cause disease (Quigley et al., 2013). A situation that compromises
pathogens without disturbing the entire microbiome could therefore enhance the immune
response of the host by maintaining the desired microbial responses to disease.

SOYBEAN-DERIVED ISOFLAVONES
Background of isoflavones
Isoflavones are antinutritional factors that have recently gained attention for their
estrogenic properties and effects on hormone-dependent and age-related diseases, such as
cancer. Isoflavones are a class of flavonoids, polyphenolic compounds commonly found
in plants and fungus that are sought after for their antioxidant, antimicrobial, anticarcinogenic, and anti-inflammatory properties. Found in legumes and soy foods, their
structures resemble estrogen, thus binding to estrogen receptors in mammals to apply
either a weak estrogenic or antagonistic effect. Hormonal regulation by the host can
decrease estrogenic binding to receptors, depending on potency of other estrogen factors.
Besides exerting estrogenic and antiestrogenic properties depending upon dosage,
isoflavones are also protein tyrosine kinase (PTK) inhibitors (Andres et al., 2007).
Genistein and daidzein are the bioactive forms that are cleaved by -glucosidases in the
gut microbiota and host cells during digestion from the zymogens genistin and daidzin.
(Chen et al., 2005). While not all soy products have the same quantity of isoflavones due
to processing methods, soybean meal, a feed ingredient regularly used in livestock diets,
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contains a modest amount that could be further supplemented to attempt to regulate
hormonal processes and enrich the gut microbiota.

Bioavailability and metabolites/digestion
Isoflavones are the most well utilized of the flavonoid family and genistein has
been proven to possess the greatest bioavailability (Yu et al., 2016). An unrefined
soybean will contain between 26-381 mg/100 g of isoflavones that gradually decreases
with degradation from processing, such as when heated. When ingested, soy isoflavones
are primarily found in the glycosidic form (daidzin, genistin, and glycitin) before βglycosidases in bacteria cleave the glycosidic groups to their aglycosidic form (daidzein,
genistein, and glycitein) in the jejunum, making them bioactive (Aglin et al., 2013). Once
activated, the isoflavones are either absorbed intact or further metabolized by the
intestinal microbiota to metabolites such as O-glucuronides, equol, and sulphate esters in
the gut barrier before metabolism in the liver (Zubik et al., 2003). S-equol, a non-steroidal
estrogen metabolized from daidzein, is only produced by 30-50% of the bacterial
population and is a potent antioxidant that binds to estrogen receptors with greater
affinity than daidzein (Frankenfeld et al., 2011). This occurs mainly when isoflavones are
not hydrolyzed or absorbed in the intestine and enter the colon. Genistein is metabolized
into dihydrogenistein by bacteria and daidzein is metabolized into dihydrodaidzein, as
shown in Figure 1. Once daidzein becomes 5-hydroxy-equol or generic equol, these
metabolites will bind to the estrogen receptors, particularly ER-β (Anupongsanugool et
al., 2005). Isoflavones may be absorbed and exert hormonal activity effects at any point
of digestion, but are dependent upon intestinal microbiota composition for the extent of
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metabolism and determining which metabolites are formed. When configuring
bioavailability and concentration of isoflavones in samples after digestion, it must be
taken into consideration that the glycosidic forms will be reduced as a consequence of the
β-glucosidase activity.

Anti-viral and anti-inflammatory properties
Inflammation is a biological response to harmful stimuli and control is tightly
regulated to prevent the over-reaction of the innate immune response. Isoflavones are
well-known for their capabilities to battle disease through their antioxidant, antimicrobial,
and anti-inflammatory properties both in vivo and in vitro. Isoflavones have been proven
to down-regulate cytokine-induced signal transduction and reduce leukocyte numbers in
the blood while decreasing IL-6, nitric oxide (NO), and prostaglandin E 2 (PGE2);
(Chinta et al., 2012). Inhibition of pro-inflammatory genes, such as COX-2 by genistein,
propose that the suppression of mediators that induce undesirable responses will delay the
onset of diseases, such as Parkinson’s Disease, with increased soy consumption. Daidzein
inhibits oxidative induction of the MAP kinase-NFκB signaling pathway that mediates
inflammatory responses and is a key factor in pathogenesis of several diseases
(Lamartiniere et al., 2002).
Antiviral properties are most elicited by genistein to inhibit the infectivity of a
range of DNA and RNA viruses. Isoflavones also influence cell membrane structures and
regulate interactions with tight junction multiprotein complexes that are activated during
stress to prevent invading pathogens from entering the enterocytes of the small intestine.
Additive immune properties from the consumption of soy-based infant formulas decrease
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rotavirus infection that causes performance loss through upset stomach that results in
diarrhea and vomiting in young mammals (Andres et al., 2007). Dietary supplementation
induces immune responses by activating factors such as cytokine production from T cells
that mobilize neutrophils to sites of infection, inhibiting natural killer cell cytotoxicity
that are crucial to the innate immune system, and even the inhibition of IgE receptor
signaling that results in the prevention of allergies (Sakai et al., 2008). When activated,
genistein has been identified as a potent inhibitor of protein tyrosine kinase (PTK)
activity associated with epidermal growth factor receptor (Brosnahan et al., 2012). PTKs
regulate cellular activities, such as cell division and in some cases, can be mutated and
result in uncontrollable cell division, resulting in cancer. Genistein has been shown to
inhibit DNA topoisomerase II, an enzyme that regulates DNA overwriting and
underwriting, and the prevention of these actions results in permanent DNA strand breaks
that overwhelm the cellular processes for repair and initiate apoptosis instead (Andres et
al., 2007). More experimentation focusing on the mechanisms of the antiviral properties
are of interest as it has not be confirmed that PTK inhibition, DNA topoisomerase II
inhibition, and timing of exposure to isoflavones have an effect on infectivity of
pathogens. It is suspected that the antiviral mechanism is related to a binding or
postbinding event in viral cell entry and replication.

Impact on microbiome
There is a dependence on the microbiome to perform metabolism, thus emphasis
is made on the intestinal bacterial profiles of the consumers to determine efficiency;
however, some phenolic compounds, such as isoflavones, have been found to be
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antimicrobial. The baseline microbiome composition dictates how polyphenols are
metabolized because both beneficial bacteria and pathogens are predisposed to
isoflavones and their inhibitory effects. Some studies have contributed the contradictory
effects of isoflavones on the bioavailability to produce equol, but recent evidence relates
these effects to the presence of sulphate reducing bacteria (Nakatsu et al., 2014). Few
studies have focused on the characterization of the microbiome with soy intake, but most
identified an increase in Eubacterium and Bifidobacterium (Paul et al., 2017).
Bifidobacteria is known to thrive off of isoflavone metabolites and it has been observed
that Clostridium is higher in abundance in individuals capable of producing equol (Bolca
et al., 2007). It would be of interest to examine human microbial populations in Asian
countries where soy is a common dietary component compared to the average Western
diet that commonly excludes soy and isolate the bacteria more abundant in the Asian
microbiome and determine which are capable of producing equol. Further
experimentation is needed to characterize the microbiota that suffer or flourish as a result
soy consumption to better understand which cultures or environments are ideal for
isoflavone supplementation.

In relation to cancer and infertility
Firm effects of isoflavones on cancer are yet to be determined; however, studies
show that higher malignancy incidences are related to S-equol binding to β-estrogenic
receptors (Anupongsanugool et al., 2005). 6’-Hydroxy-O-demethylangolensin (6’-OHDMA) is a metabolite of genistein that has stronger estrogenic properties than the parent
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compound and can be absorbed by the intestinal mucosa or the liver (Matthies et al.,
2008). 6’-OH-DMA is conjugated to O-DMA glucuronide and O-sulfate before released
into circulation or bile (Frankenfeld et al., 2011). In a more targeted approach, it was
discovered that a decrease in 17β-estradiol glucuronidation resulted in an increase in risk
of breast cancer development with excess consumption of isoflavone supplements in
patients diagnosed with ERα breast cancer (Dong et al., 2010). Cancer is a pleiotropic
disease and genistein is a pleiotropic compound, giving rise to opportunities for
undesirable events to transpire when combined. There are cases that show that the
introduction of isoflavones into cancer patients causes cell proliferation, accelerating
cancer invasion (Kurzer et al., 2000). These results depend on the health status, age, sex,
and the presence or absence of specific gut microflora as only some populations are able
to metabolize the phytoestrogens and are not as abundant in Western cultures. Most
contribute the adverse effects and increased cancer cell proliferation on the type of
estrogen receptor more prominent in the individual and if the patient is pre- or postmenopause, as women harboring more ER-α receptors that are post-menopausal are more
prone to the undesirable effects (Russo et al., 2016). Impaired fertility is another downfall
that has resulted from the use of isoflavones. In the neonatal mouse model, mice could
not deliver live pups after subcutaneous genistein exposure, showing that estrogen’s
mechanism in the female reproductive tract is mediated through ER-α (Barnes et al.,
2011). In premenopausal women, isoflavones decrease midcycle luteinizing hormone and
follicle stimulating hormone concentrations. These side effects impair growth of ovarian
follicles before the release of eggs (Kurzer et al., 2000). While women experienced a
decrease in breast cancer risk as a result of an increase in menstrual cycle length and
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decreased urinary estrogen excretion, these side effects are both indications of lower
fertility rates. In male subjects, mature sperm decrease when exposed to a high dietary
dose of genistein and reduce testis and epididymis indexes, lactate dehydrogenase, and
overall testosterone levels, negatively effecting reproductive function (Yuan et al., 2012).
Adverse effects on reproduction and in cancer patients raise concerns for the use of
dietary isoflavones and leave researchers wondering if the beneficial effects outweigh the
detrimental outcomes. The question remains how to obtain the advantageous results with
lowered risk for the unfavorable outcomes. These situations represent the need for
individual characterizations and studies because there are many factors that contribute to
the hormone therapy that ensues with isoflavones.

IPEC-J2 CELL LINE
Background
IPEC-J2 cells are a columnar intestinal porcine enterocyte cell line that are
cultured from the epithelium of the jejunum in a unsuckled neonatal piglet. They were
originally cultured by Helen Berschneider at the University of North Carolina in 1989 to
examine transepithelial ion transport and proliferation (Berschneider et al., 1989). They
are unique in that are not transformed, meaning they have a slower growth rate and lower
plating efficiency than transformed cell lines and are derived from small intestinal tissue
(Chopra et al., 2010). Small intestine cell lines have far less evidence when compared to
the colon, even though these cell lines are highly resistant to injury and when harmed,
apoptosis swiftly occurs and sloughs off the dead cells into the lumen. There is interest of
the epithelial monolayer in the gut as it serves as a physical barrier to prevent harmful
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microorganisms from invading the mucosa and averts infection. Thus, the functional
integrity of the epithelial cell lines must be able to combat the multiple mechanisms of
invasion by pathogens. IPEC-J2 are quickly becoming a prominent in cell culture studies
due to their integrity, use in numerous assays, and ease of handling.

Characterization
A polarized monolayer is formed when IPEC-J2 cells are cultured and the use of
fetal bovine serum (FBS) in the culturing medium as opposed to porcine serum results in
high transepithelial electrical resistance (TEER) to form (Vergauwen et al., 2015). The
high TEER is useful when investigating tight junctions and low active transport rates
when challenged with compounds that are harmful to monolayer permeability. Tight
junction proteins define barrier and permeability functions of the paracellular pathway
and claudin-3 and -4 and occludin have been found in the apicolateral membrane (AM),
resembling normal jejunum properties (Schierack et al., 2003). IPEC-J2 contain
microvilli on the apical membrane side, imitating extension into the lumen and are
characterized as a continuous cell line with studies using passages up to 98 (Vergauwen
et al., 2015), proving great longevity. The characterization of the IPEC-J2 cell line for
pathogenesis studies only took place in 2003 by Schierack; however, this cell line has
shown the capability to possess very similar properties to human physiology and shows
specificity to porcine-derived infections, proposing that these cells are viable for viral
studies including both human and porcine pathogens (Boyen et al., 2009).
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Immunity studies potential
IPEC-J2 cells are similar to human cell lines in that they secrete cytokines,
defensins, and toll-like receptors that all participate in communication between the
enterocytes and the innate immune system from pathogen recognition receptors.
Cytokines, such as TNF-α, are secreted by IPEC-J2 proteins and mRNA expression of
Toll-like receptor(TLRs)-2 through -10 and IL-1α, -1β, -6, -7, -8, -12A, -12B, and -18
have all been confirmed in these cells (Brosnahan et al., 2005). Presence of protein
expressions of claudin-1, -5, -7, -8 -12, and tricellulin have also been established by
immunoblotting (Zakrzewski et al., 2013), telling that a wide range of experiments may
transpire given the number of variables that can be investigated. These properties have
already been proven to be valuable in characterization of epithelial cell interactions with
enteric bacteria and viruses and make IPEC-J2 cells an ideal cell line for investigating
pathogens (Brosnahan et al., 2012). Similar responses in reference to immune parameters,
such as IL-8, have been observed in IPEC-J2 cells comparable to a human cell line,
colonic T84 cells, in response to infection (Vergauwen and Tambuyzer et al., 2015).
Advantages of using IPEC-J2 cells as a model for normal intestinal epithelial cells
include their consistency of differentiation characteristics that strongly mimic primary
intestinal epithelial cells and are directly analogous to the experimental animal that is
used as an in vivo model for humans. While originally purposed to determine ion
permeability, IPEC-J2 cells have developed into the most similar cell line of non-human
origin that can be referenced into human physiology.
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SUMMARY
The gut microbiome is becoming strongly of interest for determining and
influencing health and immunity. Manipulation of the microbial communities in the GIT
will affect the digestion and absorption of nutrients from diet that maintain intestinal
epithelial integrity and contribute to health. The symbiotic relationship between host and
gut bacteria enable access to nutrients that are not typically available from cellulose and
other fibrous compounds. The better the microbiome is understood, the more readily
available nutrients can be delivered to maximize efficiency while determining the
metabolites formed, such as those produced by isoflavones. While isoflavones have had
adverse effects on specific bacteria with antimicrobial properties, the anti-inflammatory,
antiviral, and antioxidant potential are highly sought after, and the detrimental effects
could be masked when isoflavones are used appropriately. They exert estrogenic activity
on the host while their metabolites prove to administer an even harsher effect against
pathogens and disease. To take advantage of these properties, an accurate estimation of
composition of the gastrointestinal microbiota must be determined for an individual and
which estrogen receptor present in a higher quantity identified for accurate dosage
administration of the isoflavones. While this appears to be an individualized process,
experimentation to gauge the typical abundance of isoflavone metabolizing bacteria in an
individual will allow for estimation of what could be an industry standard. These
experiments could take place in an in vivo model but are recommended in vitro first
because many immune parameters and gene expressions can be measured in a cell culture
experiment before use in live animals. The integrity of the IPEC-J2 cell line and the
numerous measurements that can be taken from this intestinal epithelial model are
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applicable to observe several immune responses that are highly reproducible. IPEC-J2
cells are robust and could be used for disease challenges to examine how the epithelial
lining reacts during times of stress and establish a baseline response of small intestine
epithelial cells to a pathogen. Gut health is a trending topic in the scientific community;
however, there is still much to characterize before manipulation of the microbiota to
optimize health and growth performance can occur. Soy isoflavones and their conflicting
results are a potential solution to the onset of disease; however, further explanation of the
mechanisms involved in immunity are needed.
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TABLE AND FIGURE
Table 1. Predicted CAZymes encoded by the genomes of selected fibrolytic gut bacteria
(Flint et al., 2012).
.
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Figure 1. Metabolic pathway of bioactive isoflavones daidzein and genistein (Kwak et al.,
2009).
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Chapter 2: Effects of carbohydrate source on performance and gastrointestinal
microbiota in nursery pigs.
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ABSTRACT
An experiment was conducted to determine the effects of carbohydrate source on
growth performance and gastrointestinal microbiota in nursery pigs. Ninety-six pigs
weaned at 21 d were randomly allotted to 16 pens (6 pigs/pen; 4 pens/treatment) with sex
represented evenly in each pen. Pigs had ad libitum access to feed and water for the 2phase nursery period (28 d). Dietary treatments included: 1) NutrisureTM (a food-grade
cooked cereal grain product), 2) oatmeal (food-grade oatmeal grain), 3) steam-rolled oats
(SRO), or 4) dried-distiller’s grains as a negative control (DDGS). Ileal and colonic
digesta and mucosa samples were collected on d 0, 14, and 28 (n = 6, 32, and 32,
respectively) for analysis of microbial species using IlluminaTM next generation
sequencing. The DNA sequences were filtered through the DADA2 pipeline, Mothur, and
QIIME. Pig body weights and feeder weights were also measured on d 0, 7, 14, 21, and
28. Pigs fed DDGS had lower average daily feed intake (ADFI) compared to other
treatments during phase 1 (P < 0.05), but there were no differences in average daily gain
(ADG) or gain:feed (G:F) among treatment. There were no differences among treatments
for ADFI, ADG, or G:F for phase 2 or the overall experimental period. Microbial
composition differed significantly among location in the gastrointestinal tract (P < 0.01)
and among the digesta and mucosa samples extracted from the ileum and colon.
Lachnospiracae pseudobutyrivibrio and butyrivibrio were identified as the species
primarily responsible for variation in sample location (P < 0.01). There were no
significant changes in the microbiota among any treatment (P > 0.10). Over time, there
was a trend (P = 0.111) for microbial diversty to vary; however, there was no interaction
among diets or as a result of sampling time point. In conclusion, carbohydrate sources did
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not affect gastrointestinal microbiota composition, ADFI, ADG, or G:F overall in this
experiment. However, feed intake during phase 1 differed between DDGS and oat-based
carbohydrate sources and microbial species were different between digesta and mucosa in
the ileum and colon.
Key words: carbohydrate sources, gastrointestinal microbiota, growth performance,
nursery pig
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INTRODUCTION
Carbohydrates are the primary source of energy for the gastrointestinal microbiota
and are used in the production of short chain fatty acids (SCFA) in the bowel as
fermentation products from food components that are not absorbed or digested in the
small intestine. Diet has been shown to affect gut microbiota composition and impact
human and swine health while preventing disease progression (Singh et al., 2017).
Bacteria in the upper intestinal tract are able to metabolize simple carbohydrates while
the latter portion includes bacteria that ferment the complex carbohydrates to break down
the more complicated -1,4 glycosidic bonds found in cellulose, a compound found in
cell walls in plants (Zoetendal et al., 2012). In order to enhance immune system response,
energy for biological processes is needed, suggesting there is reliance on the
carbohydrate structure and source ingested by the host and utilization capabilities of the
gut microbiota (Round et al., 2009). SCFA strengthen the mucosal barrier and affect
immunity by inducing responses in toll-like receptor (TLR) expression, antigen
presenting cells, differentiated T cells, among others (Flint et al., 2012). The microbiome
has the ability to affect diseases such as inflammatory bowel disease where there is less
bacterial diversity with an exclusion of prominent carbohydrate digesting bacteria such as
Bacteroides and Firmicutes (Singh et al., 2017). Evidence shows that Bacteroides and
Firmicutes interact with one another and contribute to obesity when the abundance ratios
are out of balance. When this occurs, these bacteria are able to harvest excess energy
from the host’s diet. In the small intestine, aerobic and facultative anaerobes handle
simple carbohydrates with ease in a rapid and efficient manner, while strict anaerobes
colonize in the colon and digest fiber products that must experience fermentation before
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their nutrients can be utilized (Flint et al., 2012). Understanding which bacteria are
present in various locations in the GIT makes it possible to individualize medicine and
prevent and/or treat diseases and metabolic disorders through nutritional intervention
(Filippis et al., 2018). There is interest in how diets with varying carbohydrate sources
alter alpha- and beta-diversity of the microbiome when there are varying concentrations
of readily metabolizable carbohydrates compared to nondigestible carbohydrates included
in the diet. Pigs can used as a model to determine microbial differences due to their basic
anatomical and physiological similarities to humans in digestion and absorption (Bassols
et al., 2014).
Objective: To determine the effects of simple or complex carbohydrate sources on the
gut microbiome and growth parameters of nursery piglets while characterizing the
development and location of the microbiota.

MATERIALS AND METHODS
Animals
A total of 96 terminal cross-bred barrows and gilts were randomly assigned to 16
pens with 6 pigs/pen and BW of 5.5 ± 0.5 kg with equal representation of sex in each
pen. The pigs were 21 d of age and the room holding the pigs was temperature controlled.
The experiment took place over 28 days, pigs had ad libitum access to feed and water for
the entire duration of the experiment, and sample collection of colonic and ileal digesta
and mucosa took place immediately after pigs were placed in their respective pens from
an extra 6 pigs on d 0 without being exposed to any of the nursery diets.
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Diets and Collection Method
Body weight and feeder weights were measured on d 0, 7, 14, 21, and 28 to
determine average daily feed intake (ADFI), average daily gain (ADG), and gain to feed
(G:F). Ileal and colonic digesta and mucosa samples were taken on d 0, 14, and 28 from n
= 6 on d 0 and n = 32 on d 14 and 28. The 4 diets were randomly assigned to 4 pens each
and included NutrisureTM (a food-grade cooked cereal grain product), oatmeal (foodgrade oatmeal grain), steam-rolled oats (SRO), or dried-distillers grains as a negative
control (DDGS). Diets comprised of similar inclusions of all ingredients within phase
with 10% of each carbohydrate source, except for DDGS which was includedxx at 15%,
as shown in Table 1.1 and 1.2. Less Dairy-lac 80 was needed in the Nutri-Sure and
Oatmeal diets because these ingredients already contained lactose and adjustments were
made to include 8% lactose content in every diet. Indispensable amino acids were
supplemented to meet NRC (2012) requirements for lysine, methionine, and threonine.
Calcium was supplemented by inclusion of coarse ground limestone and phosphorus was
supplemented evenly in the diets with the addition of dicalcium phosphate. In phase 2,
fish meal was not included due to satisfaction of the crude protein content using only
soybean meal and amino acid supplementation. All NRC (2012) requirements were met
by nutrient inclusions in every diet and diet composition and calculated nutrient
composition are illustrated in Tables 1.1-1.4.

DNA Isolation and Sequencing
A Mag Bind Soil DNA Kit (Omega Bio-tek, Norcross, GA), was used to extract
DNA from luminal contents and tissue scrapings in both the ileum and the colon and
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isolated in a KingFischer Isolation system (ThermoFisher Scientific, Waltham, MA). The
DNA was amplified using polymerase chain reaction and profiled for quality and quantity
with 1.5% DNA Gel Agarose Electrophoresis. Samples were then normalized using a
Charm Biotech 96 well Normalization Kit and pooled together, all using an EpMotion
Robot. Once pooled, the samples were purified using a NucleoSpin Gel and PCR CleanUp kit (Takara Bio, Mountain View, CA) and quantified with a Denovix kit and reader
(DeNovix, Wilmington, DE). Libraries were shown to be eligible for a 2 nM sequencing
run using a V2 kit with an Illumina Next Generation Sequencer.

Statistical Analysis
DNA analysis began with the filtering of sequence reads as well as trimming to
remove chimeras that could alter results. An ASV table was generated in R using Dada2
and a phylogenetic tree in Mothur. The tree was merged with the ASV table in R, a
mapping file designed for variables of interest was added, and taxa was assigned from a
Silva taxonomy package. Bray Curtis distances were generated to determine relative
abundance measure in the MicrobiomeSeq and DESeq2 packages. Amplicon sequence
variants (ASVs) were used as opposed to OTUs for more accurate analysis. The Adonis
and Permanova functions included in the Vegan package were used to generate P-values
to identify locational effects and which taxa were significantly different. RStudio was
also used to generate principal component of analysis plots from Bray Curtis values as
well as alpha diversity.
Growth performance analysis was determined with a 1-way analysis of variance
(ANOVA) conducted using the MIXED procedure of SAS 9.4 (SAS Inst. Inc., Cary, NC)
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to differentiate treatment effects at a significance level of P ≤ 0.05 and trends at a
significance level of 0.05 < P < 0.15.

RESULTS
Growth Performance
There were no effects of diet (P > 0.10) on ADFI, ADG, BW, or G:F overall.
However, there was an increase (P = 0.03) in ADFI in wk 1 and 2 for consumption of
SRO, NS, and OM diets compared to DDGS. As a result, diet produced an increase in
ADFI in phase 1 (P = 0.02); however, by the time phase 2 began and for the overall
experiment, there were no differences in growth performance among the diets. This is
shown in Figures 1.4-1.7 where no differences are detectable.

Microbiome Analysis
There were no differences in overall microbial abundances or diversity among
diets (P = 0.189), but a trend for time to affect microbial composition (P = 0.111). The
location that samples were isolated from had varying microbial abundances (P = 0.003),
leading to further analysis to determine which of the 4 locations were different. While it
was determined that mucosa and digesta differ from each other (P = 0.001), they do not
differ when extracted from the ileum versus the colon (P > 0.10). Lachnospiraceae
Pseudobutyrivibrio and Lachnospiraceae Butyrivibrio were the top 2 families that caused
differences and were most prominent in the mucosa compared to the digesta (P < 0.01).
Prevotellaceae Prevotella_1 was found in the colonic mucosa (CM) more than any other
location (P < 0.01), Ruminococcaceae Faecalibacterium was of great abundance in the
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ileal digesta (ID) (P < 0.01), and Lachnospiraceae Lachnoclostridium was the most
present genus in the colonic digesta (CD) (P < 0.01) When comparing colonic digesta
and mucosa, there was a greater abundance of Helicobacteraceae Helicobacter,
Campylobacteraceae Campylobacter, Prevotellaceae Prevotellaceae, and Rikenellaceae
Rikenellaceae_RC9_gut_group in the mucosa (P < 0.01) and Erysipelotrichaceae
Erysipelotrichaceae and Lactobacillaceae Lactobacillus in the digesta (P < 0.01). The
comparison between ileal mucosa (IM) and CD showed a greater abundance of
Ruminococcaceae Subdoligranulum, Prevotellaceae Prevotella, Muribaculaceae,
Prevotellaceae Prevotellaceae_NK3B31_group, Veillonellaceae Megasphaera,
Lachnospiraceae Coprococcus_3, Lachnospiraceae Dorea, Ruminococcaceae
Ruminococcaceae, Veillonellaceae Dialister, and Streptococcaceae Streptococcus in the
colon (P < 0.01). The contrasts between ID and CM showed a greater abundance of
Campylobacteraceae Campylobacter, Muribaculaceae, Prevotellaceae
Prevotellaceae_NK3B31_group, Prevotellaceae Prevotella_2, Rikenellaceae
Rikenellaceae_RC9_gut_group and Enterobacteriaceae Escherichia/Shigella in the CM
(P < 0.01). The ileal components were compared and showed a greater abundance of
Veillonellaceae Dialister, Streptococcaceae Streptococcus, Lactobacillaceae
Lactobacillus, Bifidobacteriaceae Bifidobacterium, Coriobacteriaceae Olsenella, and
Clostridiaceae_1 Clostridium_sensu_stricto_1 in the ID (P < 0.01) while a great amount
of unidentified bacteria were prominent in the IM (P < 0.01).

46
DISCUSSION
Growth performance was not affected by diet overall; however, growth
performance was affected in weeks 1 and 2 and phase 1. The greater consumption of
SRO, NS, and OM diets compared to the DDGS could be due to the sweeter smell of
these diets that are higher in starch and more palatable (Seabolt et al., 2010). If the piglets
are more likely to eat this diet in the first phase after weaning when stress is high, it’s
worth noting that if there’s a supplement that requires enhanced feed intake, these diets
would be better to feed than the DDGS. While there was a difference in feed intake, there
were still no differences in ADG, G:F, or BW, meaning that even though the feed was
more well liked, it was not more efficient and cost should be taken into consideration
when feeding these diets if more product is used with less utilization in the body.
The gut microbiota composition and diversity were measured in 4 locations in the
GIT including; luminal contents in the ileum and colon (ID, CD) and scrapings in the
ileum and colon (IM, CM). Figure 1.3 shows the consistency in bacterial diversity among
diets, but how composition changes in different sampling locations. There is also a
presence of the Planctomycetes and Cyanobacteria phyla in this figure, bacteria that are
found in chloroplasts and participate in photosynthesis. They are included in this study
because when isolating DNA from the luminal contents, plant DNA residues were
sequenced because they were extracted from the soybean meal and corn that the pigs
ingested and were moving through the lumen at the time of sampling. The principal
component analysis plot in Figure 1.2 shows the clustering of sample location, where
clustering of one color represents that variable as being similar to itself and not to other
locations. The abundance of Lachnospiraceae Pseudobutyrivibrio and Lachnospiraceae
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Butyrivibrio were the most different among sampling location and these taxonomies are
common to the gut and degrade complex polysaccharides to SCFA (Sagheddu et al.,
2016). These families were harbored in the lining of the gut and protect against infections
in the humans. It has been shown that low-level subtherapeutic antibiotics optimize
Lachnospiraceae colonization in the infant mouse and contribute to the development in
diabetes (Kameyama et al., 2014), most likely due to their energy precursor producing
abilities.
In the CM, Prevotellaceae Prevotella_1 genus was most abundant and secretes
ghrelin, a gut hormone that maintains dopamine function and upholds GIT motility
(Gerhardt et al., 2018). Campylobacteraceae Campylobacter colonized in the CM, as
well and is found in house flies and it has been previously shown that a majority of C.
Campylobacter contain virulence genes and antibiotic resistance (Scanlon et al., 2013).
This species is closely related to Muribaculaceae that was also found in the CM as a
result of the ingestion of flies by the pigs. As far as public health concern goes, this
discovery should not be of concern if pork is properly cooked and this genus could be a
target for research to better understand the mechanisms of antibiotic resistance.
Helicobacteraceae Helicobacter is a known agent of gastrointestinal disease; however,
some species are not pathogenic (Oxley et al., 2004). Rikenellaceae
Rikenellaceae_RC9_gut_group had high presence in the CM and participates in lipid
metabolism, commonly leading to obesity and diabetes (Cani et al., 2013). The bacteria
present in the CM, the most diverse location in the GIT, showed many beneficial bacteria
that participated in membrane integrity, while there were species that are pathogenic.
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This could suggest that there are parts of the GIT that are more prone to infection than
others and the source of stress is identifiable based on the type of infection.
In the CD, the abundant Ruminococcaceae Subdoligranulum and
Ruminococcaceae Ruminococcaceae have been proven to affect gut barrier function and
participate in colonization resistance against Clostridium difficile, a bacterium associated
with antibiotic-associated diarrhea (Pérez-Cobas et al., 2014). Veillonellaceae
Megasphaera are a commensal bacterium with a genome involved in metabolism of
proteins and amino acids as well as carbohydrates that produce end products beneficial to
the host, such as SCFA, vitamins, and co-factors for other necessary cell functions
(Shetty et al., 2013). Lachnospiraceae Coprococcus_3 is a known butyrate producer, one
of the major sources of energy to the colonic mucosa cells that also participates in
regulating gene expression, inflammation, differentiation, and apoptosis (Noriega et al.,
2016). The two Prevotellaceae groups, Prevotellaceae Prevotella and Prevotellaceae
Prevotellaceae_NK3B31_group were among the top 10 families most abundant in the
CD, which could be the result of sloughing of the intestinal lining, as these genus’s are
commonly found in the mucosa. The Lachnospiraceae Dorea is a major gas producer in
the GIT with glucose fermentation end products including hydrogen and carbon dioxide
(Taras et al., 2002). Veillonellaceae Dialister has been shown to increase the amount of
circulating IL-6 in the blood serum, a cytokine that communicates with the host to
stimulate the immune system (Martinez et al., 2012). Lastly, Streptococcaceae
Streptococcus was abundant in the CM and is known to cause infections, such as
pharyngitis and impetigo (Walker et al., 2014). The presence of both the beneficial and
degenerative bacteria agrees with the findings in the CM that pathogenic bacteria may
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reside in a specific location in the GIT and medicine may be targeted towards those areas
to prevent an imbalance in earlier sections of the intestine from the effects of antibiotics.
The digesta samples were not as diverse as the mucosa samples; however, there
were certain genus’ that appeared more often in the digesta than the mucosa.
Veillonellaceae Dialister and Streptococcaceae Streptococcus were shown to be in a high
abundance in the luminal contents more than in the lining. Lactobacillaceae
Lactobacillus were also copious and is commonly found in probiotics as this genus is
involved in carbohydrate metabolism to produce lactic acid (Walter et al., 2008).
Bifidobacteriaceae Bifidobacterium are among the first bacteria that colonize in the GIT
and are also probiotic organisms that perform health-promoting actions and also
participate in carbohydrate metabolism (Egan et al., 2018). The Coriobacteriaceae
Olsenella genus is present in both healthy and acidotic animals and is involved in
carbohydrate metabolism, producing lactic acid in ruminants and non-ruminants from
various carbohydrate sources (Kraatz et al., 2010). The Firmicutes family in the ileal
bacteria community was composed of a high presence of Clostridiaceae_1
Clostridium_sensu_stricto_1 for protein and amino acid metabolism and utilization (Fan
et al., 2017); however, it has been shown that a decrease in dietary protein results in an
increase in this strain of bacteria and improvement of ileal barrier integrity. The digesta is
continuously moving through the GIT and is subjected to many more microbes than the
stationary mucosa; however, it maintains less diversity.
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CONCLUSION
Growth performance and the overall gut microbiome were not affected by time or
diet; however, there were differences in microbial composition when comparing the
luminal contents and lining. These observations suggest that sample extraction from the
colon may be representative for bacteria present in the ileum if the microbes isolated are
from the mucosa or the digesta, but not intermixed. Energy producing bacteria were also
found in both the ileum and the colon, showing that microbes in the latter portion of the
intestine do not rely on the energy produced in the former. Complex carbohydrates that
are broken down during fermentation are useful to supplement these bacteria to keep
communities diverse and efficient. The Lachnospiraceae family of the Clostridiales order
is the main cause for variation between digesta and mucosa while originally assumed to
have been most prominent in the mucosa. This observation agrees with previous studies
that have shown a greater abundance in the mucosal lining that affects gut integrity and
energy production. There are many species that differ from sampling location, both
beneficial and pathogenic, suggesting that phenotype may be influenced by
supplementation that targets specific sections of the GIT. It is of interest to determine if
treatment of one part of the intestine without disrupting the microbiome in other parts can
improve immune status of a sick individual through preservation of the unaffected
microorganisms that produce health-enhancing co-products. Further characterization of
the microbiome and the production of metabolites may help provide opportunity for
specific outcomes through nutritional intervention.
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TABLES
Table 1.1. Ingredient composition (% as-fed bases) of diets for Phase 1.
Ingredients, %
DDGS SRO NS OM
Corn
32.6
36.5 39.1 40.3
Soybean meal, Dehulled, Solvent Extracted 32.0
33.0 33.0 33.0
Fish Meal
7.00
7.00 7.00 7.00
Corn DDGS, > 6% and < 9% oil
15.0
0.00 0.00 0.00
Steam-Rolled Oats
0.00
10.0 0.00 0.00
Nutrisure
0.00
0.00 10.0 0.00
Oatmeal
0.00
0.00 0.00 10.0
Dairylac-80
8.00
8.00 5.40 4.20
Corn Oil
3.00
3.00 3.00 3.00
Dicalcium Phosphate 18.5% P
0.40
0.65 0.65 0.70
Coarse Ground Limestone
0.85
0.70 0.65 0.62
L-Lys-HCl
0.32
0.32 0.34 0.34
DL-Met
0.04
0.04 0.06 0.06
L-Thr
0.06
0.10 0.12 0.12
Sodium Chloride
0.30
0.30 0.30 0.30
1
Vitamin Premix
0.25
0.25 0.25 0.25
2
Trace Mineral Premix
0.15
0.15 0.15 0.15
1

Vitamin premix supplied per kg of diet: vitamin A (as retinyl acetate), 5500 IU; vitamin
D (as cholecalciferol), 550 IU; vitamin E (as tocopherol acetate), 30 IU; vitamin K (as
menadione dimethylpyrimidinol bisulfate), 4.4 mg; riboflavin, 11.0 mg; d-pantothenic
acid, 22.05 mg; niacin, 33.0 mg; vitamin B12 (as cyanobalamin), 33.0 mg.
2
Trace mineral premix: copper (as CuSO45H2O), 10 mg/kg; iodine (as Ca(IO3) ∙ H2O),
0.25 mg/kg; iron (as FeSO4 ∙ 2H2O), 125 mg/kg; manganese (MnO), 15 mg/kg; selenium
(Na2SeO3), 0.3 mg/kg; zinc (ZnSO4 ∙ H2O), 125 mg/kg.
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Table 1.2. Calculated nutrient composition of diets for Phase 1.
Calculated nutrient composition, % DDGS SRO NS
OM
1
ME , kcal/kg
3446 3357 3499 3502
Crude protein
27.1 25.0 24.8 25.0
2
SID AA, %
Arg
1.52 1.48 1.46 1.46
His
0.60 0.56 0.56 0.56
Ile
0.95 0.89 0.89 0.89
Leu
1.96 1.68 1.71 1.72
Lys
1.51 1.50 1.50 1.50
Met
0.45 0.45 0.43 0.43
Met+Cys
0.77 0.76 0.73 0.73
Phe
1.09 1.00 1.00 1.00
Phe+Tyr
1.85 1.67 1.66 1.66
Thr
0.89 0.88 0.89 0.89
Trp
0.26 0.26 0.25 0.25
Val
1.06 0.98 0.97 0.97
3
STTD Phosphorus
0.45 0.45 0.44 0.45
Total Phosphorus
0.71 0.72 0.72 0.72
Calcium
0.85 0.85 0.85 0.85
Fermentable fiber
14.7 12.0 11.2 11.3
NDF
10.1 7.14 6.27 6.38
Starch
22.5 27.5 30.9 30.6
Sugar
7.81 7.85 7.87 7.92
1
2

ME: metabolizable energy
STTD: standardized total tract digestible; SID: standard ileal digestibility

57
Table 1.3. Ingredient composition (% as-fed bases) of diets for Phase 2.
Ingredients, %
DDGS SRO NS OM
Corn
36.8 40.7 43.3 44.5
Soybean meal, Dehulled, Solvent Extracted
38.0 39.0 39.0 39.0
Fish Meal
0.00 0.00 0.00 0.00
Corn DDGS, > 6% and < 9% oil
15.0 0.00 0.00 0.00
Steam-Rolled Oats
0.00 10.0 0.00 0.00
Nutrisure
0.00 0.00 10.0 0.00
Oatmeal
0.00 0.00 0.00 10.0
Dairylac-80
4.00 4.00 1.40 0.14
Corn Oil
3.00 3.00 3.00 3.00
Dicalcium Phosphate
1.10 1.35 1.40 1.40
Coarse Ground Limestone
1.05 0.90 0.80 0.85
L-Lys-HCl
0.26 0.28 0.30 0.30
DL-Met
0.04 0.04 0.08 0.08
L-Thr
0.00 0.06 0.06 0.06
Sodium Chloride
0.30 0.30 0.30 0.30
1
Vitamin Premix
0.25 0.25 0.25 0.25
2
Trace Mineral Premix
0.15 0.15 0.15 0.15

1

Vitamin premix supplied per kg of diet: vitamin A (as retinyl acetate), 5500 IU; vitamin
D (as cholecalciferol), 550 IU; vitamin E (as tocopherol acetate), 30 IU; vitamin K (as
menadione dimethylpyrimidinol bisulfate), 4.4 mg; riboflavin, 11.0 mg; d-pantothenic
acid, 22.05 mg; niacin, 33.0 mg; vitamin B12 (as cyanobalamin), 33.0 mg.
2
Trace mineral premix: copper (as CuSO45H2O), 10 mg/kg; iodine (as Ca(IO3) ∙ H2O),
0.25 mg/kg; iron (as FeSO4 ∙ 2H2O), 125 mg/kg; manganese (MnO), 15 mg/kg; selenium
(Na2SeO3), 0.3 mg/kg; zinc (ZnSO4 ∙ H2O), 125 mg/kg.
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Table 1.4. Calculated nutrient composition of diets for Phase 2.
Calculated nutrient composition, % DDGS SRO NS
OM
1
ME , kcal/kg
3446 3357 3499 3502
CP
27.1 25.0 24.8 25.0
2
SID AA, %
Arg
1.52 1.48 1.46 1.46
His
0.60 0.56 0.56 0.56
Ile
0.95 0.89 0.89 0.89
Leu
1.96 1.68 1.71 1.72
Lys
1.51 1.50 1.50 1.50
Met
0.45 0.45 0.43 0.43
Met+Cys
0.77 0.76 0.73 0.73
Phe
1.09 1.00 1.00 1.00
Phe+Tyr
1.85 1.67 1.66 1.66
Thr
0.89 0.88 0.89 0.89
Trp
0.26 0.26 0.25 0.25
Val
1.06 0.98 0.97 0.97
2
STTD Phosphorus
0.45 0.45 0.44 0.45
Total Phosphorus
0.71 0.72 0.72 0.72
Calcium
0.85 0.85 0.85 0.85
Fermentable fiber
14.7 12.0 11.2 11.3
NDF
10.1 7.14 6.27 6.38
Starch
22.6 27.5 30.9 30.6
Sugar
7.81 7.85 7.87 7.92
1
2

ME: metabolizable energy
STTD: standardized total tract digestible; SID: standard ileal digestibility
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FIGURES
Figure 1.1. Alpha Diversity measures of location samples were extracted (Sampletype)
compared among diets.
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Figure 1.2. Relative abundance principal component of analysis plot with variables
sample type versus diet.
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Figure 1.3. Phylum composition of sampling site bacterial communities by diet for ID,
CD, IM, and CM.
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Figure 1.4. Average daily gain within diet in wk 1-4.
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Figure 1.5. Average daily feed intake within diet in wk 1-4.
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Figure 1.6. Gain:feed within diet in wk 1-4.
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Figure 1.7. Body weight within diet on d 0, 7, 14, 21, and 28.
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Chapter 3: Effects of soybean-derived isoflavones on nursery pig growth
performance, microbiome, and immune parameters.
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ABSTRACT
The effects of soybean-derived isoflavones on the microbiome, growth
performance, and interleukin-8 (IL-8) were observed in nursery pigs. Sixty-four pigs
weaned at 21 d were randomly allotted to 16 pens (4 pigs/pen; 4 pens/treatment) with sex
represented evenly in each pen. Pigs had ad libitum access to feed and water for the 2phase nursery period (28 d). Dietary treatments included: 1) Hamlet protein’s HP-300
(highly digestible soybean meal product), 2) HP-300 + Novasoy 400 (isoflavone
supplement), 3) Arcon-F (soy protein concentrate in place of soybean meal), and 4)
Arcon-F + Novasoy 400. Fecal samples were collected on d 0, 14, and 28 (n = 32) as well
as blood samples for IL-8 enzyme-linked immunofluorescence assay (ELISA) while ileal
and colonic mucosa and digesta samples were collected solely on d 28 (n = 16) for
analysis of microbial species using IlluminaTM next generation sequencing. The DNA
sequences were filtered through the DADA2 pipeline, Mothur, and QIIME. Pig body
weights and feeder weights were also measured on d 0, 7, 14, 21, and 28 (n = 64) for
growth performance analysis. There were no differences in growth performance for body
weight (BW), average daily feed intake (ADFI), average daily gain (ADG), or gain:feed
(G:F); (P > 0.10). While diet did not affect the amount of circulating IL-8, there was an
increase in the concentration of blood serum IL-8 over time (P < 0.001). Diet, day, and
sample location caused differences in microbial composition (P < 0.01) with most
variation resulting from the Arcon-F diet that had a lower presence of the Chlamydiae,
Fusobacteria, and Proteobacteria phylums. The composition of bacteria varied over time
with an increase in Chlamydiae, Vertebrata, Cyanobacteria, and Spirochaetes by d 14 (P
< 0.001), but these differences were not detected between d 14 and 28. Colonic digesta
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was the least diverse with a decrease in many phyla, most notably Bacteroidetes,
Firmicutes, Cyanobacteria, and Actinobacteria (P < 0.005).
Key words: gastrointestinal microbiota, immunity, isoflavones, nursery piglets

67
INTRODUCTION
With the introduction of the Veterinary Feed Directive and consumer demands,
most producers are moving towards using feed ingredients that improve gut health with
nutritional intervention in production to amplify the immune system and decrease the use
of antibiotics. A member of the legume family, soybeans are inexpensive and easily
processed to a defatted version that is popular to consume for both humans and animals.
In swine, soybean meal is a common ingredient used for its high protein content and
digestibility with over 4.06 billion bushels of soybeans produced in the U.S. in 2016
alone, with numbers increasing annually (Schulz et al., 2016). Once the hulls are
removed, the soybean oil is extracted and the solvent is removed, the leftover flakes are a
product high in quality protein content with most anti-nutritional factors removed
(Johnson et al., 1995). In processed soybean meal, the phytoestrogens classified as
isoflavones remain intact and retain bioactivity to influence many immune parameters of
interest. Isoflavones are ingested mainly in their glycosidic form (daidzin, genistin, and
glycitin) before β-glycosidases that reside in bacteria and the epithelial lining of the host
cleave the glycosidic groups to their aglycosidic form (daidzein, genistein, and glycitein);
(Aglin et al., 2013). Resembling estrogen, isoflavones exert either weak estrogenic or
antagonistic effects conditionally, depending on the age, health status, sex, and the
composition of the gut microbiome in the host. Genistein and daidzein are the bioactive
forms formed during digestion from the gut microbiota and cells from zymogens genistin
and daidzin; however, there is interest in the metabolite equol as it may have enhanced
estrogenic activity than these two compounds combined (Anupongsanugool et al., 2005).
Isoflavones are of interest due to their anti-inflammatory, antiviral, and antimicrobial

68
properties as well as in some cases, relieving cancer patients; however, adverse effects in
cancer patients suggest that there are appropriate situations to use the compounds,
depending on if the patient has more estrogen receptor (ER) α or β (Russo et al., 2016).
There is interest to understand which gut microbes are able to digest the isoflavones and
produce the beneficial metabolites that induce the immune system to increase circulating
cytokines, maintain a diverse and healthy gut microbiome to combat disease when
introduced, maintain intestinal epithelial integrity, and positively effect growth
performance.
Objective: To determine the effects of isoflavones derived from a soybean meal product
compared to a soy protein concentrate with low anti-nutritional factors and an isoflavone
concentrate added to both products (Arcon-F, Arcon-F + Novasoy 400, HP-300, HP-300
+ Novasoy 400) on nursery pig growth, feed efficiency, gastrointestinal microbiota, and
interleukin-8.

MATERIALS AND METHODS
Animals
Piglets (n = 64; WXL/DNA Genetics Landrace/DNA Genetics Yorkshire x DNA
Genetics Duroc) were weaned at 21 d of age and allotted to 16 experimental pens with
equal representation of sex in each pen (n = 4, males = 2, females = 2), similar body
weight (BW) of 5.5  0.5 kg, and nearly even distribution of litters. Pigs were given ad
libitum access to feed and water throughout the experiment. All lights in the experimental
room remained on 24 h/d throughout the duration of the experiment. Room temperature
was 28 C during wk 1 and dropped by 2 degrees each wk, thereafter heat lamps were
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used during the first 2 wk to provide extra heat inside the pens. The entire experiment
lasted for an interval of 28 d and sample collection of feces occurred after pigs were
positioned in their respective pens on d 0, 14, and 28 from n = 32 pigs and diets were
randomly assigned. Ileal mucosa (IM), ileal digesta (ID), colonic mucosa (CM), and
colonic digesta (CD) samples were also obtained on d 28 from n = 16 pigs. Body weight
and feeder weights were recorded on d 0, 7, 14, 21, and 28 to estimate average daily feed
intake (ADFI), average daily gain (ADG), and gain:feed (G:F).

Diets
Four dietary treatments were fed in 2 phases and all diets were similar to a cornsoybean meal diet formulated to meet nursery pig requirements based on weight (NRC,
2012). The high bioavailable protein soybean product HP-300 (Hamlet Protein; Findlay,
OH) and Arcon-F, a soy protein concentrate (ADM; Chicago, IL) were used to replace
SBM and are referred to as HP-300 and Arcon-F diets, respectively. Diets were also
formulated with these products combined with Novasoy 400 (ADM; Chicago, IL) to add
supplemental isoflavones. The 2 diets with extra isoflavones were formulated to contain
similar inclusions of isoflavones at 2,011 mg/kg and are referred to as HP+NS (HP-300 +
Novasoy 400) or AF+NS (Arcon-F + Novasoy 400). These inclusions were determined
by the concentration of isoflavones in a typical soybean meal diet and referencing
literature that has included isoflavones up to 2,500 mg/kg in the diet while accounting for
a margin of safety to prevent the deleterious effects. Similar nutrient content was
maintained among diets within phase with no antibiotics or ZnO. Each diet phase was fed
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for 2 wk and ingredient inclusion and calculated nutrient composition for each diet and
phase is illustrated in Tables 2.1-2.4.

Data Collection
Feed disappearance and individual pig BW were measured weekly for 4
consecutive weeks post-weaning for the determination of average daily gain (ADG),
average daily feed intake (ADFI), and gain:feed (G:F). Fecal and blood samples were
collected on d 0, 14, and 28 from 2 pigs in each pen. Blood samples were analyzed for
IL-8 concentrations in the serum and feces were used for characterization of the
microbiome. Pigs (n = 16) were euthanized at the end of the study on d 28 and mucosal
scrapings, and luminal contents from both the ileum and colon were collected for DNA
analysis and microbiome composition determination.

DNA Isolation and Sequencing
A Mag Bind Soil DNA Kit (Omega Bio-tek, Norcross, GA), was used to extract
DNA from luminal contents and tissue scrapings in both the ileum and the colon as well
as from fecal samples. The obtained DNA was isolated in a KingFischer Isolation system
(ThermoFisher Scientific, Waltham, MA) and amplified using polymerase chain reaction
and profiled for quality and quantity with 1.5% DNA Gel Agarose Electrophoresis.
Samples were then normalized and purified using an NGS Normalization 96-well kit
(Norgen Biotek Corp, Thorold, Ontario) and pooled together. Samples were quantified
with a Denovix kit and reader (DeNovix, Wilmington, DE) and purity assessed with a
High Sensitivity DNA kit, chip, and Bioanalyzer (Agilent, Santa Clara, CA) to ensure
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dimers were removed and peak concentrations were high enough. Libraries were found to
be eligible for a 2 nM sequencing run using a V2 kit with a Next Generation Sequencer
(Illumina, San Diego, CA).

IL-8 ELISA
A DuoSet ELISA Porcine IL-8/CXCL8 kit was used to measure porcine
Interleukin 8 in serum isolated from blood. All reagents were brought to room
temperature before use and components were allowed to sit for a minimum of 15 minutes
with gentile agitation after initial reconstitution. Working dilutions were prepared and
used immediately, except for the Wash Buffer and Reagent Diluent. The Capture
Antibody was diluted to working concentration in PBS without the carrier protein and
immediately used to coat a 96-well microplate, sealed, and incubated overnight at room
temperature. The next day, wells were aspirated and washed with Wash Buffer 3 times
using a manifold dispenser. The plate was then blocked with Reagent Diluent and
incubated at room temperature for at least 1 hour and washed again. The samples were
then added to the wells in duplicate to enhance reproducibility, covered with an adhesive
strip, and incubated at room temperature for 2 hours. The plate was then washed before
the Detection Antibody, diluted in Reagent Diluent and Normal Goat Serum, was added
to each well, covered with a new adhesive strip, and incubated for 2 hours at room
temperature. Samples were then washed before a working dilution of Streptavidin-HRP
was added to each well and incubated for 20 minutes at room temperature while covered
and out of direct light. The wash step occurred once more before the Substrate Solution
was added to each well incubated for 20 minutes at room temperature out of direct light.
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The Stop Solution was then added to each well and the plate was gently tapped to ensure
thorough mixing before the optical density of each well was determined. The microplate
reader was set to 450 nm and wavelength correction at 540 nm.

Statistical Analysis
The DNA analysis began with the filtering of sequence reads as well as trimming
to remove chimeras that may skew results. An ASV table was generated in R using
Dada2 and a phylogenetic tree in mothur. The tree was merged with the ASV table in R,
a mapping file designed for variables of interest was added, and taxa were assigned from
a Silva taxonomy package. Bray Curtis distances were generated to determine relative
abundance measures in the MicrobiomeSeq and DESeq2 packages. Amplicon sequence
variants (ASVs) were used as opposed to OTUs for more accurate analysis. The Adonis
and Permanova functions included in the Vegan package were used to generate p-values
to identify locational effects and which taxa were significantly different. R was also used
to generate principal component of analysis plots from Bray Curtis values as well as
alpha diversity.
Growth performance analysis was performed using a 1-way analysis of variance
(ANOVA) conducted using the MIXED procedure of SAS 9.4 (SAS Inst. Inc., Cary, NC)
to differentiate treatment effects at a significance level of P ≤ 0.05 and trends at a
significance level of 0.05 < P < 0.15.
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RESULTS
Growth performance
Diet did not effect ADG, ADFI, BW, or G:F (P > 0.10). Body weight averaged
15.20 kg by day 28 with an ADG of 1,276.8 g. There was a decrease in feed intake for all
pigs receiving diets during wk 4, with wk 3 averaging 1,170 g per diet per day while
ADFI in wk 4 was only 793 g/d. No differences were observed at specific weeks or
phases (P > 0.10); however, there was a trend for G:F to be greater in the Arcon-F +
Novasoy 400 diet during wk 1 and 3 (P = 0.113).

Microbiome analysis
Significant differences in microbial composition and diversity were observed
among diets, the location the samples were isolated from, and over time. The diets that
produced significantly different microbial composition were the Arcon-F diet that
maintained less diversity while the Arcon-F + Novasoy 400 saw an increase in abundance
of genus’. The AF diet showed an increased abundance of the phyla Chlamydiae,
Fusobacteria, and Proteobacteria (P < 0.005; Table 2.8). Genus’ that were less abundant
were Veillonella, Lactobacillus, Christensenella, Lachnospiraceae, Chlamydia,
Actinobacillus, Sphingomonas, and Bifidobacterium (P < 0.001). At the phylum level,
AFNS showed an increase in Ruminococcaceae, Syntrophococcus, Allisonella,
Schwartzia, Sanguibacteroides, Leptotrichia, Slackia, Collinsella, Olsenella,
Enterococcus, Truicibacter, and Shuttleworthia (P < 0.001)..
The microbiome became increasingly diverse over time (P = 0.001) as shown in
Figure 2.1. After d 0, there was an increase in several genus’ including Euryarchaeota,
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Verrucomicrobia, Planctomycetes, Synergistetes, Actinobacteria, and Lentispharerae (P
< 0.001). By d 14, there was a greater abundance of Chlamydiae, Vertebrata,
Cyanobacteria, Fibrobacteres, Spirochates, Epsilonbacteraeota, Deferribacteres,
Tenericutes, and Patescibacteria (P < 0.001).
Microbial diversity varied between sampling location (P = 0.001) with most of
the variation occurring in the CD; however, there was variation in the CM, as well. There
was a decrease in abundance of Blautia, Marvinbryantia, Fusicatenibacter, Dorea,
Lachnospiraceae, Oribacterium, Dialister, Allisonella, Megasphaera, Mitsuokella,
Selenomonas, Acidaminococcus, Phascolarctobacterium, Oscillibacter, Anaerofilum,
Angelakisella, Faecalibacterium, Subdoligranulum, Pygmaiobacter, and Butyricicoccus
in the CD (P < 0.001). The CM showed an upregulation of Vibrionimonas,
Sediminibacterium, Chlamydia, Klebsiella, Escherichia Shigella, Mycoplasma,
Pelomonas, Pseudomonas, Stenotrophomonas, Bradyrhizobium, Methylobacterium,
Helicobacter, and Bacillus (P < 0.001). Microbial composition of the feces was not
different from the CD (P > 0.05).
The top 10 families responsible for diversity differences included
Ruminococcaceae, Lachnospiraceae, Shuttleworthia, Allisonella,Slackia, Angelakisella,
Turicibacter, Clostridium, Veillonella, and Negativabacillus in decreasing order (P <
0.001).

IL-8 ELISA
The IL-8 concentration in blood serum did not change with diet (P > 0.10);
however, there was an increase in circulating IL-8 over time (P < 0.001), except for in the
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Arcon-F diet. This diet showed a decrease in IL-8 in the blood serum by d 28 as shown in
Figure 2.7.

DISCUSSION
No differences were observed among diets for growth performance as ADG,
ADFI, G:F, and BW remained consistent within phase. While there is always an interest
in using products in diets that cause pigs to perform better than others, growth
performance in this study cannot be included as a reason for microbiome diversity
changes and the differences in observations can be reserved strictly for the variables of
interest, diet, time, and sampling location.
The differences observed in microbial composition caused by diet were primarily
in the diets containing the Arcon-F product. The AF diet showed less abundance of many
bacteria that are typically high in the piglet microbiome. Of these, Veillonella is an early
colonizer that forms a mutually beneficial relationship with the host through its role in
lactic acid metabolism (Periasamy et al., 2010). Lactobacillus is also a beneficial
bacterium that was found in lower abundance, putting these animals at a disadvantage in
not being able to utilize their health-promoting properties, even though this species does
not typically colonize in the gut, but is allochthonous (Walter et al., 2008).
Lachnospiraceae also colonize early and participate in carbohydrate metabolism to
produce SCFA, energy sources for the microbiome (Sagheddu et al., 2016). Schwartzia is
another phylum that produces energy for the GIT bacteria using succinate, a common
metabolite in cellular processes, such as the citric acid cycle (Gylswyk et al., 1997). If the
colonization of this phylum is inhibited, it’s questionable how efficient these animals will
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be in production if energy sources are few. Bifidobacterium is also involved in initial
establishment in the GIT with probiotic actions exerted on the host, especially infants as
this phylum is attuned to metabolism of milk oligosaccharides (O’Callaghan et al., 2016).
Christensenella has been shown to be the most heritable of the gut bacteria and is directly
related to obesity. This phylum has been found in higher abundance in individuals with a
lower body mass index and combats obesity by decreasing adipose deposits (Madsen et
al., 2017). The Sphingomonas phylum dwindled in the AF diet as well and has been
shown to contribute to the immune response by producing glycolipids for natural killer T
cells that ward off infection (Caballero et al., 2015). From a beneficial standpoint, it was
observed that there was a downregulation of Chlamydia that resides in the gut as an
opportunistic pathogen (Rank et al., 2014). Once infection ensues, the immune system is
unable to clear the Chlamydiae entirely, thus a lower initial presence is desirable. The
same concepts apply for Actinobacillus, as this phylum has been related to numerous fatal
diseases and is inactively harbored in the GIT until infection is triggered (Rycroft et al.,
2000). The AFNS diet showed increases in abundance of bacteria more than any other
diet. Among these phyla was Ruminococcaceae that has been associated with individuals
that maintain high energy metabolism (Menni et al., 2017). Allisonella has been shown to
increase insulin resistance and tumor necrosis factor, leading to endotoxemia and small
intestinal bacterial growth (Catinean et al., 2018). Collinsella was upregulated in the
AFNS diet and can alter the host bile acids to regulate the virulence and pathogenicity of
enteric pathogens (Gomez-Arango et al., 2018). Leptotrichia and Enterococcus are other
opportunistic pathogens that mainly reside in the oral cavity and ferment carbohydrates to
produce lactic acid in both the mouth and the GIT (Eribe et al., 2008). Species of the
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genus Slackia that were found in high abundance are known to produce equol from
isoflavones in the human intestine (Jin et al., 2009). If more equol producing bacteria are
present where supplemental isoflavones have greater inclusion, there is more opportunity
for utilization of the metabolites and ability to study the effects. Upregulation of
Syntrophococcus was observed, a phylum able to metabolize isoflavones and was present
in the diet containing supplemented isoflavones. These bacteria have been shown to
participate in O-demethylation of monoaromatic derivatives in the rumen, such as the
formation of O-DMA (Doré et al., 1990). Greater abundance of isoflavone metabolizing
microbes was shown in the diet that included supplemental isoflavones, proposing that
these bacteria will colonize in the microbiome if isoflavones are included in diet in the
early stages of life.
Alpha diversity as shown in Figures 2.1 and 2.3 identifies differences in the
number of species present in day and sample location; however, there were evidently
similar numbers of bacteria in diet, as shown in Figure 2.2. Euryarchaeota are of interest
as they are organisms known to survive in even the most extreme conditions, potentially
able to thrive when disease occurs (Castro-Fernandez et al., 2017). Planctomycetes,
Lentispharerae, and Verrucomicrobia that metabolize methane were shown to increase
over time, highlighting the diversity that increases in the microbiome in even just two
weeks (Lee et al., 2009). The integrity of the microbiome was enhanced as
Actinobacteria increased, a prominent member of the gut microbiome that produces
antibiotics (Ventura et al., 2007), providing a defense mechanism for both the bacteria
and the host. The microbiome diversity continued to proliferate with more of the
prominent genus’, such as Cyanobacteria and Fibrobacteres becoming more abundant
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with the change from the phase 1 to phase 2 diets. Fibrobacteres participates in cellulose
metabolism and as more fiber was included in the diet, the more opportunity for this
genus to thrive (Ransom-Jones et al., 2012). The increase of Chlamydiae showed that
beneficial bacteria weren’t the only ones able to colonize, as this opportunistic pathogen
was able to gain access to the GIT and find it’s niche (Rank et al., 2014).
Epsilonbacteraeota have been shown to be early colonizers in previous studies (Methou
et al., 2019) as symbiotic bacteria, observations verified with the indication of high
abundance in the nursery phase of piglets. There was an upsurge of
Epsilonproteobacteria, Patescibacteria, and Deferribacteres, genus’ known for the
utilization of iron and reduction of nitrate (Gittel et al., 2012), showing how the microbes
are able to break down more material in the gut as more bacteria colonize. Tenericutes
further shows the increase in diversity by being one of the few bacteria that do not
possess a peptidoglycan cell wall (Skennerton et al., 2016). An increase in the abundance
and diversity of these vastly different bacteria represent how much the microbiome can
develop in a short time period.
Sample location was shown to affect microbial composition, especially in the
colon where luminal contents were much less diverse than colonic mucosa. In the digesta,
there were many genus’s accounted for that were in less abundance, including both
beneficial and pathogenic bacteria. It is understandable that more bacteria are present in
the lining, the greater opportunity for colonization compared to the digesta that is
constantly moving through the GIT until it is expelled from the body, thus bacteria must
constantly be competing for a spot in the lining to maintain their niche and stay in the
body. Some of the bacteria in the digesta could be present only due to the sloughing of
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the intestinal walls that force them into the lumen. It is worth nothing that the fecal
samples were similar to the colonic digesta samples, thus feces may be used for microbial
analysis of the colonic digesta that uses a less invasive method for collection.
IL-8 circulating in the blood serum was not different among diets; however, it did
increase over time. Studies have shown that as mammals mature, their immune systems
are more suited to focus on stimulating factors that give the organism an advantage
against potential pathogens by promoting synthesis and secretion of cytokines
(Carstensen et al., 2010). While IL-8 may not have been mobilized with the inclusion of
isoflavones, other cytokines and TNF-α concentrations would be of interest, because only
1 cytokine does not mean an increase or decrease in gut health or immunity.

CONCLUSION
There were no differences in growth performance or circulating IL-8 among diet
(P > 0.10) for this experiment; however, there is evidence that diet, time, and location of
sample extraction all affect the gut microbiome composition. Arcon-F, the diet with
essentially no inclusion of isoflavones decreased in microbial diversity compared to the
other diets (P < 0.001), while the Arcon-F + Novasoy 400 diet had greater concentrations
of notable bacterium, including those that can metabolize isoflavones into equol (P <
0.01). The HP-300 and HP-300 + Novasoy 400 diets did not show any significant
differences within this threshold of analysis. Between d 0 and 14 of the experiment, there
was a shift in the microbiota with significant changes even in the first phase as a result of
the switch in diet (P < 0.001). This suggests that the microbiome is easily affected during
the first stages of life and is rapidly changing during this time with the introduction of
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new feed and/or a new environment. The location in the gastrointestinal tract has varying
microbial composition as well, as mucosa and digesta samples differ considerably (P <
0.05). However, feces and colonic digesta are close enough in composition that if one is
interested in CD microbial structure, taking fecal samples will suffice as a less invasive
method. A decrease in beneficial bacteria in the GIT of pigs fed soy protein concentrate
diet with no isoflavones suggests that some species of bacteria thrive off of the
phytoestrogens and other compounds typically found in SBM that are removed during
processing. These bacteria may be involved in gut barrier function and integrity. Further
experimentation should take place with a disease challenge where piglets are infected
with a pathogen after ingesting varying doses of isoflavones and immune parameters and
the microbiome again analyzed.

IMPLICATIONS
During wk 4, there was a decrease in ADFI and ADG compared to wk 3. This is
not typical to experimentation as growth and feed intake usually only increase the with
the duration of the experiment. There could also be upregulation or downregulation of
bacteria in the diets that were not included in the top 10 families; however, our analysis
only included those families most prominent.
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TABLES
Table 2.1. Ingredient composition (% as-fed bases) and calculated nutrient composition
of diets for Phase 1.
Diets

Ingredients, %
Corn
Dicalcium phosphate,
18.5% P
Limestone
Salt
Vitamin premix1
Trace mineral premix2
Corn Oil
Lysine·HCl
DL-Methionine
L-Threonine
Whey, dried
Dairylac-80
HP-300
Novasoy 400
Arcon-F
Calculated nutrient
composition, %
Crude protein
ME (kcal/kg)3
Ca
STTD4 P
SID4 Lys
SID Met
SIDl Thr
SID Trp
Total Lysine
Total Phosphorus
Ca:P
Isoflavones (mg/kg)
1

HP-300

HP-300 +
Novasoy 400

Arcon-F

Arcon-F +
Novasoy 400

42.3

41.9

42.5

41.9

1.05
1.07
0.10
0.25
0.15
3.00
0.45
0.14
0.11
15.2
11.3
25.0
0.00
0.00

1.05
1.07
0.10
0.25
0.15
3.00
0.45
0.14
0.11
15.2
11.3
25.0
0.35
0.00

1.10
1.00
0.10
0.25
0.15
3.00
0.21
0.32
0.02
15.2
11.3
0.00
0.00
25.0

1.10
1.00
0.10
0.25
0.15
3.00
0.21
0.32
0.02
15.2
11.3
0.00
0.50
25.0

29.7
3530
0.80
0.40
1.35
0.40
0.79
0.23
1.48
0.62
1.29
604

29.7
3518
0.80
0.40
1.35
0.40
0.80
0.23
1.48
0.61
1.31
2011

22.5
3037
0.80
0.40
1.36
0.40
0.80
0.23
1.40
0.62
1.29
0

22.5
3037
0.80
0.40
1.36
0.40
0.80
0.23
1.40
0.62
1.29
2011

Vitamin premix supplied per kg of diet: vitamin A (as retinyl acetate), 5500 IU; vitamin D (as
cholecalciferol), 550 IU; vitamin E (as tocopherol acetate), 30 IU; vitamin K (as menadione
dimethylpyrimidinol bisulfate), 4.4 mg; riboflavin, 11.0 mg; d-pantothenic acid, 22.05 mg; niacin, 33.0 mg;
vitamin B12 (as cyanobalamin), 33.0 mg.
2
Trace mineral premix: copper (as CuSO45H2O), 10 mg/kg; iodine (as Ca(IO3) ∙ H2O), 0.25 mg/kg; iron (as
FeSO4 ∙ 2H2O), 125 mg/kg; manganese (MnO), 15 mg/kg; selenium (Na 2SeO3), 0.3 mg/kg; zinc (ZnSO4 ∙
H2O), 125 mg/kg.
3
ME: metabolizable energy
4
STTD: standardized total tract digestible; SID: standard ileal digestibility
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Table 2.2. Ingredient composition (% as-fed bases) and calculated nutrient composition
of diets for Phase 2.
Diets

Ingredients, %
Corn
Dicalcium phosphate, 18.5%
P
Limestone
Salt
Vitamin premix1
Trace mineral premix2
Corn Oil
Lysine·HCl
DL-Methionine
L-Threonine
Whey, dried
Dairylac-80
HP-300
Novasoy 400
Arcon-F
Calculated nutrient
composition, %
Crude protein
ME3, kcal/kg
Ca
STTD4 P
SID4 Lys
SID Met
SIDl Thr
SID Trp
Total Lysine
Total Phosphorus
Ca:P
Isoflavones (mg/kg)
1

HP-300

HP-300 +
Novasoy 400

Arcon-F

Arcon-F +
Novasoy
400

45.7

45.3

45.9

45.4

0.70
1.07
0.10
0.25
0.15
3.00
0.41
0.13
0.11
15.2
11.3
22.0
0.00
0.00

0.70
1.07
0.10
0.25
0.15
3.00
0.41
0.13
0.11
15.2
11.3
22.0
0.37
0.00

0.70
1.00
0.10
0.25
0.15
3.00
0.20
0.28
0.02
15.2
11.3
0.00
0.00
22.0

0.70
1.00
0.10
0.25
0.15
3.00
0.20
0.28
0.02
15.2
11.3
0.00
0.50
22.0

27.1
3536
0.70
0.33
1.24
0.37
0.74
0.20
1.37
0.55
1.27
532

27.1
3524
0.70
0.33
1.23
0.37
0.74
0.20
1.35
0.53
1.32
2019

20.8
3103
0.70
0.33
1.24
0.36
0.74
0.21
1.36
0.53
1.32
0

20.8
3103
0.70
0.33
1.24
0.36
0.74
0.21
1.36
0.53
1.32
2019

Vitamin premix supplied per kg of diet: vitamin A (as retinyl acetate), 5500 IU; vitamin D (as
cholecalciferol), 550 IU; vitamin E (as tocopherol acetate), 30 IU; vitamin K (as menadione
dimethylpyrimidinol bisulfate), 4.4 mg; riboflavin, 11.0 mg; d-pantothenic acid, 22.05 mg; niacin, 33.0 mg;
vitamin B12 (as cyanobalamin), 33.0 mg.
2
Trace mineral premix: copper (as CuSO45H2O), 10 mg/kg; iodine (as Ca(IO3) ∙ H2O), 0.25 mg/kg; iron (as
FeSO4 ∙ 2H2O), 125 mg/kg; manganese (MnO), 15 mg/kg; selenium (Na 2SeO3), 0.3 mg/kg; zinc (ZnSO4 ∙
H2O), 125 mg/kg.
3
ME: metabolizable energy
4
STTD: standardized total tract digestible; SID: standard ileal digestibility
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FIGURES
Figure 2.1. Bacterial alpha diversity over time for days 0, 14, and 28.
Bacterial Alpha Diversity by Sample Day
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Richness: the number of species per sample; The more species present in a sample, the 'richer' the sample.
Simpson alpha diversity index: the number of organisms of a particular species (n) over the total number of
organisms of all species (N) subtracted from 1.

Shannon diversity index: the calculated proportion of species i relative to the total number of species (pi),
multiplied by the natural logarithm of this proportion (lnpi), multiplied by -1.

(*) = (P < 0.05)
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Figure 2.2. Bacterial alpha diversity for overall experimental diets.
Bacterial Alpha Diversity by Diet
Richness
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Richness: the number of species per sample; The more species present in a sample, the 'richer' the sample.
Simpson alpha diversity index: the number of organisms of a particular species (n) over the total number of
organisms of all species (N) subtracted from 1.

Shannon diversity index: the calculated proportion of species i relative to the total number of species (pi),
multiplied by the natural logarithm of this proportion (lnpi), multiplied by -1.
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Figure 2.3. Bacterial alpha diversity compared between sample locations (SampleType).
Bacterial Alpha Diversity by Sample Type
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Richness: the number of species per sample; The more species present in a sample, the 'richer' the sample.
Simpson alpha diversity index: the number of organisms of a particular species (n) over the total number of
organisms of all species (N) subtracted from 1.

Shannon diversity index: the calculated proportion of species i relative to the total number of species (pi),
multiplied by the natural logarithm of this proportion (lnpi), multiplied by -1.

(*) = P < 0.05, (***) = P < 0.001)
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Figure 2.4. Principal Component of Analysis plot for time of sample collection versus
diet.
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Figure 2.5. Principal Component of Analysis plot for time of sample collection versus
location of sample.
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Figure 2.6. Principal Component of Analysis plot for diet versus location of sample.
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Figure 2.7: ELISA results of diet over time in pg/mL.

800

Concentraion of IL-8 (pg/mL)

700
600
500
400
300
200
100
0
AF

AFNS
d0

HP
d14

d28

HPNS

93
Figure 2.8. Phylum composition of sampling site bacterial communities as shown within
diet.
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Figure 2.9. Top 10 species diversity in diets.
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Figure 2.10. Average daily gain within diet in wk 1-4, phase 1-2, and overall.
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Figure 2.11. Average daily feed intake within diet in wk 1-4, phase 1-2, and overall.
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Figure 2.12. Gain:feed within diet in wk 1-4, phase 1-2, and overall.
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Figure 2.13. Body weight within diet on d 0, 7, 14, 21, and 28.
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Chapter 4: Determination of immune responses in an intestinal epithelial cell line
treated with varying doses of genistein and the individual isoflavones.
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ABSTRACT
Two experiments were conducted where IPEC-J2 cells were treated with varying
concentrations of the isoflavone genistein or similar concentration of each of the
isoflavones genistin, genistein, daidzin, and daidzein. In the first experiment, cells were
split into 12 6-well plates with 50,000 cells per well in transmembrane wells and treated
with varying concentrations of genistein (0, 50, 150, and 300 M), lipopolysaccharides
(LPS), or polyinosinic:polycytidylic acid (poly I:C). In the second experiment, cells were
split into 12 6-well plates with 75,000 cells per well and treated with individual
isoflavones at a concentration of 50 M, while poly I:C was included as well as
diclofenac sodium salt. In both experiments, media was extracted from the basolateral
membrane (BLM) and apical membrane (AM) for IL-8 ELISA analysis after plates were
incubated at 37 C and 5% CO2 at hours 0, 3, 6, and 12. Transepithelial electrical
resistance (TEER) was measured on the plates that were used for hour 12 collection of
media. In Exp. 1, treatment did not cause a difference in IL-8 (P > 0.10), but there was an
increase in IL-8 present in the media with time (P < 0.001) and between BLM and AM (P
< 0.005). Treatment did cause differences in Exp. 2 (P = 0.0186) where poly I:C secreted
more IL-8 overall and daidzin was the most anti-inflammatory isoflavone in this
experiment, suggesting that it is rapidly converted into daidzein in the intestinal
membrane.
In both Exp. 1 and 2, there were no differences for overall TEER (P > 0.10). In
Exp 1., LPS produced a greater epithelial resistance by hour 12 (P = 0.014) than the other
treatments. The genistein treatments did not produce greater TEER than LPS; however,
all 3 genistein treatments averaged greater TEER than poly I:C and 0 M. The 50 M
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genistein treatment had greater TEER and IL-8 secretion than 150 or 300 M, thus this
concentration was used in Exp. 2 to for optimize membrane integrity. In both
experiments, more IL-8 was secreted into the BLM, which simulates the barrier between
the enterocytes and the blood (P < 0.01). In both experiments, there was an increase in
IL-8 secretion over time (P < 0.05), imitating production of the chemokine in the GIT. It
was determined that 50 M of isoflavones is an adequate concentration to treat cells with
for immune studies. In Exp. 2, the isoflavones did not produce as great of concentration
of IL-8 as the poly I:C, suggesting that they prevent inflammatory responses from
occurring. They also did not degrade the epithelial lining to the point of dysfunctionality
and thus may be used in IPEC-J2 cell line experiments.
Key words: genistein, interleukin-8, IPEC-J2, transepithelial electrical resistance
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INTRODUCTION
Soy as a protein source is becoming increasingly popular in Western diets due to
the discovery of numerous benefits associated with the high soy content in Asian diets.
Soybean meal is a popular protein source in swine diets due to low cost and high
digestibility. In soy, estrogen-shaped compounds known as isoflavones are found as
daidzin, genistin, and glycitin, the glycosidic forms (Izumi et al., 2000). Isoflavones have
been shown to influence immune parameters in mammals; however, the appropriate
composition of the gut microbiome is required to produce the desired metabolites that
elicit such responses. Found in soy, isoflavones are still commonly considered to be antinutritional factors because they have been shown to increase cell proliferation in some
cases, causing quicker progression of some cancers (Khan et al., 2012). Daidzein and
genistein are the active forms that are cleaved in the gastrointestinal tract from their
glycosidic forms, daidzin and genistin, by β-glycosidases (Yu et al., 2016). Isoflavones
have been proven to impact immunity and influence the concentration of circulating
cytokines in the blood while influencing gut barrier function and membrane integrity
(Gilbert et al., 2013). Genistein has been proven to retain antiviral, anti-inflammatory,
and antimicrobial properties and is known as the bioactive isoflavone (Chinta et al.,
2012). Structurally similar to estrogen, genistein exerts estrogenic and anti-estrogenic
activity on the host. While many characteristics of genistein are desirable, studies have
shown either drastic upregulation or downregulation of cell proliferation in incidences
that either damage crypt cells in the jejunum or increase proliferation to the point that
cancer occurs (Dong et al., 2010). Daidzein forms the metabolite S-equol that is more
estrogenic and a more potent antioxidant than daidzein that binds to estrogen receptors
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with more affinity (Kobayashi et al., 2013). To better understand how to take advantage
of the anti-inflammatory, antiviral, and antimicrobial properties that have been found in
some cases, research must take place to determine the mechanisms of immune responses
elicited by the isoflavones individually and as a mixture. It has been reported that
isoflavones are involved in interactions that enrich the immune response (Yu et al.,
2016); however, individual isoflavone responses should be characterized first to
understand the contribution that each makes to the innate immune system. IPEC-J2 cells
are a non-transformed epithelial cell line cultured from the jejunum of an unsuckled
neonatal piglet. These cells are ideal to measure membrane integrity and cytokine
production before introducing to a live animal (Brosnahan et al., 2012). These cells
mimic the intestinal wall lining when cultured in transmembrane well inserts, including a
basolateral membrane side (BLM) that represents the barrier between enterocytes and the
blood, while the apical membrane (AM) symbolizes the membrane between the cells and
the lumen (Chopra et al., 2010). The innate immune system will secrete proinflammatory and anti-inflammatory cytokines into both the BLM and AM, and IPEC-J2
cells have been found to secrete both into the media on either side of the transmembrane
well insert. They are capable of being models for the intestinal lining as they are robust
cells that can maintain function up to 100 passages and still produce immune responses
when treated with compounds of interest, such as genistein (Vergauwen et al., 2015).
There are typical concentrations of genistein in products such as soy-based infant
formulas and soybean meal; however, supplementation of excess isoflavones, including
genistein, is of interest and determination of the threshold appropriate to include is still
being researched. In order to harness the benefits without experiencing the adverse
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effects of isoflavones, different doses of isoflavones both individually and mixed must be
explored. The IPEC-J2 cell line is useful for determination of maximum and minimum
treatment exposure while using a more cost-effective method than an in vivo trial, first.
Objective: To determine the appropriate concentration of genistein to use as a baseline in
cell culture experiments with IPEC-J2 cells and other isoflavones while maintaining
intestinal integrity through measurements of cytokine production and transepithelial
electrical resistance to rationalize use of treatments in further research, including disease
challenges and observing the immune effects of other isoflavones.

MATERIALS AND METHODS
Cell culture
IPEC-J2 cells were brought to confluency in two 75 cm2 flasks and split into n =
12 6-well plates with 0.4 μm pore transmembrane well cell culture inserts (Falcon,
Corning, NY) in a density of 50,000 cells per well in Exp. 1 and 75,000 cells in Exp. 2.
Cells were brought to ≥95% confluency before media was aspirated, washed with PBS,
and treated for 1 hour with the designated treatments. Once the hour was over, media was
again aspirated and cells were washed with PBS before being cultured with a 1:1 ratio of
Dulbecco’s Modified Eagle Medium (ThermoFischer Scientific, Waltham, MA) and
Ham’s F-12 Nutrient Mixture (Gibco, ThermoFischer Scientific, Waltham, MA), 10%
fetal bovine serum (FBS), 10 L/ 2.0 L epidermal growth factor (EGF), 1%
penicillin/streptomycin, and 1% insulin/transferrin/Na selenite media supplement.
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Treatments
In Exp. 1, cells were treated with 4 concentrations of genistein (from Glycine
max, soybean, ~98% HPLC, Sigma-Aldrich, St. Louis, MO) at 0, 50, 150, or 300 M.
These treatments were determined by the average concentration of isoflavones in a
typical soybean meal diet commonly used in the industry and supplementation up to 6
times the normal dose. These concentrations have commonly been found to lie within a
margin of safety where the deleterious effects of isoflavones do not normally occur. The
remaining cells were exposed to either 10 ng/L lipopolysaccharides (LPS) or 20 g/mL
polyinosinic:polycytidylic acid (poly I:C). The 0 M treatment was used as a control
while LPS and poly I:C were used as negative controls since they are known to elicit
innate immune system responses and possess pro-inflammatory properties. In Exp. 2,
cells were treated with 50 M of either genistein (from Glycine max, soybean, ~98%
HPLC), genistin (from Glycine max, soybean, 95% HPLC), daidzein (98%, synthetic),
and daidzin (95% HPLC) (Sigma-Aldrich, St. Louis, MO). Cells were also treated with
0.2 mM diclofenac sodium salt as a positive control. 20 g/mL polyinosinic:polycytidylic
acid (poly I:C) was used as a negative control in the final well of the 6-well plate.
Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) and is appropriate to use
as a positive control while poly I:C was used as a negative control as it produces proinflammatory cytokines in a natural setting.

Sample collection and analysis
Samples were collected at hours 0, 3, 6, and 12 from 3 plates in the BLM and AM
while TEER was measured in the 3 plates that were used through hour 12. TEER was
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measured using an EVOM Epithelial Voltohmmeter (World Precision Instruments,
Sarasota, FL) with STX2 chopstick electrodes. The electrodes were placed on each side
of the well insert membrane and measured in ohms. Samples were stored in 1.5 mL
microcentrifuge tubes at -20 C until used for ELISA. A Human IL-8/CXCL8 DuoSet
ELISA and DuoSet ELISA Ancillary Reagent Kit 2 were used on samples that were
plated in duplicate to enhance reproducibility and ensure accuracy of the spectrometer. A
FLUOstar Omega microplate spectrometer was used to determine concentration of IL-8
in the wells in picograms/microliter. Both IL-8 and TEER values were analyzed for
differences using a repeated measures analysis of variance (ANOVA) for TEER and oneway ANOVA for IL-8 in R (R studio, 3.6.0, The R Project) to differentiate treatment
effects at a significance level of P ≤ 0.05 and trends between 0.05 < P > 0.15.

IL-8 ELISA
A DuoSet ELISA Porcine IL-8/CXCL8 kit was used to measure porcine
Interleukin 8 in serum isolated from blood. All reagents were brought to room
temperature before use and components were allowed to sit for a minimum of 15 minutes
with gentile agitation after initial reconstitution. Working dilutions were prepared and
used immediately, except for the Wash Buffer and Reagent Diluent. The Capture
Antibody was diluted to working concentration in PBS without the carrier protein and
immediately used to coat a 96-well microplate, sealed, and incubated overnight at room
temperature. The next day, wells were aspirated and washed with Wash Buffer 3 times
using a manifold dispenser. The plate was then blocked with Reagent Diluent and
incubated at room temperature for at least 1 hour and washed again. The samples were
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then added to the wells in duplicate to enhance reproducibility, covered with an adhesive
strip, and incubated at room temperature for 2 hours. The plate was then washed before
the Detection Antibody, diluted in Reagent Diluent and Normal Goat Serum, was added
to each well, covered with a new adhesive strip, and incubated for 2 hours at room
temperature. Samples were then washed before a working dilution of Streptavidin-HRP
was added to each well and incubated for 20 minutes at room temperature while covered
and out of direct light. The wash step occurred once more before the Substrate Solution
was added to each well incubated for 20 minutes at room temperature out of direct light.
The Stop Solution was then added to each well and the plate was gently tapped to ensure
thorough mixing before the optical density of each well was determined. The microplate
reader was set to 450 nm and wavelength correction at 540 nm.

RESULTS
Interleukin-8
In Exp 1., IL-8 did not differ between treatments (P > 0.10); however, secretion of
IL-8 overall increased over time (P < 0.001) as shown in Figure 4.1. There was also a
greater concentration of IL-8 secretion in the BLM when compared to the AM (P <
0.001).
In Exp. 2, the poly I:C treatment produced the greatest secretion of IL-8 of the
treatments (P = 0.0186) while daidzin stimulated the least amount of release, as shown in
Figure 5.1. The more that time went on, the more IL-8 that was released into the media
with the greatest increase in cytokine production taking place between hours 6 and 12 (P
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< 0.001). There was an increase in the concentration of IL-8 as samples were taken from
the basolateral membrane (P = 0.016).

Transepithelial electrical resistance
In Exp. 1, TEER proved to vary both among treatments and over time. LPS
produced greater membrane integrity (P = 0.0137) than the other treatments, while 150
M of genistein produced the lowest. Intestinal integrity increased considerably over
time (P = 0.0107) with the 6-hour time interval between hours 6 and 12 showing a
dramatic increase in ohms.
In Exp. 2, there was not a difference in TEER among treatments (P > 0.10), nor
were there any differences over time (P > 0.10). This is illustrated in Figure 5.2 where the
electrical resistance is measured and represented in ohms against time samples were
collected on hours 0, 3, 6, and 12.

DISCUSSION
Genistein did not prove to be more proactive in IL-8 secretion than the LPS;
however, it was also not lower than the 0 M control or poly I:C negative control. There
were not statistically significant differences between treatments; however, Figure 4.2
shows that LPS increased substantially faster than the other treatments if more time was
allowed with the 50 M genistein treatment closely behind. 50 M genistein produced
better IL-8 secretion in the BLM and AM compared to 150 M and 300 M, suggesting
that a lower concentration more closely related to genistein concentrations in industry
products should suffice for further in vitro analysis without degrading the cells. BLM had
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more IL-8 secretion than AM as expected, reaffirming that this cell line is useful in
determining how the concentrations of cytokines released into the blood circulation
operate instead of being wasted in the lumen. The LPS treatment was greater in TEER
while 50 M genistein was its closest competitor. With this concentration of genistein
producing better immune responses than the general control or negative control, it can be
concluded as an appropriate dosage of genistein to use in this model for further analysis
of other individual isoflavones, as well as a disease challenge.
Individual isoflavones did not induce a more prominent innate immune response
than the negative control, poly I:C, or the positive control, diclofenac. While this may
seem contradictory, poly I:C is, in general, an immunostimulant and has been proven to
stimulate chemokines in a manner similar to lipopolysaccharides (LPS) which is
commonly used as a negative control. While it is unclear why that scenario occurred in
this trial, the number of studies that observed similar outcomes ensure that poly I:C is not
exclusively a pro-inflammatory cytokine producer. The isoflavones caused less IL-8
secretion, suggesting a lower stimulation of inflammatory compounds while potentially
exerting an anti-inflammatory effect. There were no differences in TEER for treatment or
time, while time is typically seen to increase epithelial integrity. This could differ in this
trial from the cells having been seeded into the wells heavier and given 5 days instead of
7 to become confluent and start building integrity on the transmembrane cell culture
insert. There was no difference caused by treatment either, which is reassuring that the
isoflavones may be cultured individually on these cells without degrading them.
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CONCLUSION
Genistein in concentrations 150 and 300 M did not produce a greater innate
immune response than LPS; however, 50 M of genistein was second best and still above
the control and negative control responses. There were no overall significant differences
in treatment for IL-8 (P > 0.10); however, IL-8 secretion was significantly higher in the
BLM (P < 0.001) and increased over time (P < 0.001). Treatment with LPS caused the
cells to have greater TEER (P = 0.0137) which gradually increased with time (P =
0.0107) with the most drastic change between hours 6 and 12. Genistein in a 50 M
concentration is sufficient for further cell culture experimentation while minimizing cost.
The remaining isoflavones should be tested at this concentration compared to genistein;
however, it is important to note that genistein is the bioactive isoflavone and a mixture of
isoflavones should be tested as well to look for interactions.
The individual isoflavones secreted less IL-8 than the controls did, suggesting that
a general control should be used during further experimentation to ensure that they still
are producing a positive immune response. There was an increase in IL-8 from each
treatment over time, which agrees with our previous experiment. While there wasn’t a
large difference observed in IL-8 concentrations among the controls in this experiment, it
gives reason to believe that isoflavones can be cultured on IPEC-J2 cells safely. This
gives way to future experiments that can include how cells treated with isoflavones and
infected with a pathogen compare to cells treated with isoflavones that have not
undergone infection. The TEER results support this statement because there wasn’t an
increase in intestinal integrity, nor was there a decrease. Another factor of interest in
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future studies could be the regulation of MUC-2, the prominent mucin producing gene in
cells that could explain how mucosal lining is affected, as well.
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FIGURES

Figure 4.1. IL-8 concentrations in the BLM and AM in Exp. 1 over time expressed as
picograms/microliter.
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Figure 4.2. IL-8 concentration in the BLM over time in Exp. 1 expressed as
picograms/microliter.
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Figure 4.3. IL-8 concentration in the AM over time in Exp. 1 expressed as
picograms/microliter.
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Figure 4.4. Transepithelial electrical resistance of treatments over time in Exp. 1.
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Figure 4.5. IL-8 concentrations in the BLM and AM in Exp. 2 over time expressed as
picograms/microliter.
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Figure 4.6. IL-8 concentration in the BLM over time in Exp. 2 expressed as
picograms/microliter.
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Figure 4.7. IL-8 concentration in the AM over time in Exp. 2 expressed as
picograms/microliter.
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Figure 4.8. Transepithelial electrical resistance of treatments over time in Exp. 2.
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ASV Comparison Between Chapter 2 and Chapter 3
When comparing microbiome studies, amplicon sequence variants (ASVs) are
commonly used for their reusability, reproducibility, and resolution. In order to establish
a baseline microbiome for nursery piglets, metanalysis of studies that sequence GIT
samples are possible through the use of ASVs instead of operational taxonomic units
because the variation and errors in the DNA sequence are able to be traced to the location
of the base pairs. The microbiome data from chapters 2 and 3 were merged and analyzed
using simper, a function of the vegan package in R. This function discriminates species
using Bray Curtis dissimilarities and displays the most important species for each group
that contribute to at least 70% of the differences between variables.
In chapters 2 and 3, diets were compared and a few bacteria causing differences
were Prevotella, Clostridium, Lactobacillus, and Ruminococcaceae with most variance
occurring as a result of the Prevotella abundance. As previously mentioned, Prevotella is
the most abundant species in the adult GIT and it would be of interest to determine which
diets contributed to colonization for this species and why it is the most abundant.
Clostridium is a prominent butyrate producer, ferments amino acids, and is found in
higher abundance in those individuals that are able to produce equol. The comparisons
could be done to determine if the diets containing a greater inclusion of isoflavones do
have a greater presence of this bacteria. Lactobacillus is commonly found in probiotics
and assists in carbohydrate fermentation. Chapter 2 explores the effects of varying
carbohydrate sources on the microbiome and one or all of these diets could cause greater
colonization when compared to chapter 3. Ruminococcaceae caused the most variation in
microbial composition in chapter 3 and is a common carbohydrate fermenter. There
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appears to have been a difference in carbohydrate fermentation among the two studies
when analyzing diets. More analysis should be done to determine if the piglets ingesting
the varying carbohydrate sources will be more adept to ferment carbohydrates based on
the colonization of the species containing the carbohydrate active enzymes.
Sampling location was compared among the studies and it has already been
determined that microbial composition varies significantly based on the location the
samples were isolated from in both chapters 2 and 3. Again, Prevotella was the most
prominent species for producing differences, telling that not only does diet affect
colonization, but this bacterium is colonizing in one section of the GIT more than the
other. Ruminococcaceae and the uncultured Anaerorhabdus bacterium were at the top of
the list for variation. Ruminococcaceae, like Prevotella, suggests that diet affects the
colonization in various parts of the GIT. The presence of Anaerorhabdus reminds
researchers that there is still much to learn about the structure and function of the
gastrointestinal microbiome, but that we are getting closer.
The microbial composition over time was analyzed and Prevotella was the
bacteria that accounted for the most variation. It is again, the most abundant species in
the adult, and the observation that the abundance is changing over time in a nursery piglet
is not surprising. Oscillibacter, a species known to cause bacterium, fluctuated with time,
possibly either by the reduction of the species over time after the piglets recover from the
weaning stress, or possibly colonizes more over time as each bacterium establishes its
niche in the GIT. The abundance of Roseburia also varied with time; however, this
species is a commensal bacteria that produces SCFA, especially butyrate, giving it
potential to act as a marker of health or serve as a biomarker for symptomatic
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pathologies, such as the formation of gallstones. While there are many species that
account for differences over time, the diversity of these three account for the theory that
the immune system is gradually becoming stronger with the colonization of certain
microbes; however, the interaction of the GIT microbiota within itself and with the host
could cause functional differences and contributions.
Merging ASVs allows for the reproducibility of studies to be accounted for in
research while also contributing to the discovery of microbial composition, the similar
species among trials, and which variables (day, diet, sampling location, etc.) cause
diversity differences. The contribution of each microbiome trial to a greater study will
allow a core microbiome to eventually be established and perhaps even allow individual
studies to compare microbial sequences to a large database to determine the differences
of their own study to the “norm” and make it easier to locate which bacteria are not
typically found in the pig microbiome, but were abundant in their trial. While
composition is important, there must also be more research to determine the function of
each of the microbial species because just knowing that a species is abundant does not
provide researchers with the information of what that actually means for the structure and
function of the GIT and what those microbes contribute to the host. Merging these two
ASVs is a start for determining microbial similarities in the nursery piglet and is just a
fraction of what might soon contribute to a core piglet microbiome.
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APPENDIX
DNA Extraction and Sequencing Protocol
DNA Extraction
Kit: Mag Bind Soil DNA kit. 4 x96 preps (Omega)
Set watch bath/incubator to 90˚C
Heat elution buffer to 70˚C- optional
Prepare ice bucket
Chill centrifuge to 4˚C for second centrifugation step
1) Place beads in rounded part of a 2 mL safe-lock tube
2) Add 0.125-0.25 g of sample to tube. Sample tubes can be frozen until needed to
extraction.
3) Add 300 uL SLX-Mlus buffer. I use 700 uL for fecal samples to prevent sludge
problems.
4) Use tissue lyzer to beat bead tubes for 10 min at frequency 20
5) Spin down foam by centrifuging at 5000 x g for 2 min at room temp.
Gets the foam off the cap.
6) Add 30 uL DS buffer and 2 uL RNase A
a) 30 uL x 110 rxns = 3.3 mL
b) 2 uL x 110 rxns = 220 uL
c) Mix together in a small conical tube
d) Dispence 32 uL to each tube
7) Vortex to mix thoroughly.
8) Place tubes in 90˚C water bath for 5-7 min.
9) Briefly vortex tubes once during incubation. I do this after 3.5 min.
10) Centrifuge 5000 x g for 10 at room temp.
11) Transfer 1000 uL supernatant into a new set of 1.5mL tubes.
a) You likely won’t have this much. Don’t be afraid to transfer cloudly liquid.
12) Add 67 uL of SP2 buffer and 67 uL cHTR reagent
a) Warm up cHTR to 37˚C to make sure there are no solids in the bottle. Put back
in fridge after use.
b) Solution will be very thick to add. Sanitize a razor blade and cut the tip off a
pipette tip for use.
13) Vortex to mix.
14) Let sit on ice for 5 min.
15) Centrifuge at 5000 x g for 10 min at 4˚C.
16) Transfer the supernatant into a new tube. You may have to take some sludgy stuff.
17) Can leave at this step for overnight.
Preparation of nucleic acids – do prior to extraction
18) Make 100 mL of 70% EtOH (make fresh everytime)
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19) Make 10 mM sodium acetate
a) g needed = MW (g/mol) x volume needed (L) x final conc (M)
b) 82.03 g/mole x 0.05 L x 0.01 M = 0.041 g measured into 50 mL ddiH20
20) Get ice bucket
21) Put EtOH and isopropanol into ice bucket
22) Make 10 mM Tris at pH 8
a) Tris base = 121 g/mol
b) To make 1 L
i. 10 mM = 0.01 M
ii. (0.01 mol/L) * (121 g/mol) = 1.21 g/L
iii. Sterilize by autoclave
iv. Let cool to room temp
v. pH to 8 (for 250 mL I added approximately 30 uL, but adjust as needed)
Note: pH solution prior to autoclaving if you are worried about sterility.
pH shouldn’t change much.
23) Add 10 mM of sodium acetate to each lysate tube, vortex gently, and incubate on ice
for 5 min (solution is to 0.2X of beginning volume)
a. 350 uL * 0.2 = 70 uL added, I would just add 70 uL regardless of volume
24) Centrifuge tubes at 16,000 x g for 15 min at 4˚C.
25) Transfer supernatant into new 1.5 mL tube
a. If less than 650 uL transfer all to one tube. There likely won’t be more than 600
uL
26) Add one volume (same amount as supernatant from previous step) of isopropanol to
supernatant tube and vortex
a. I added 300-400 uL
27) Incubate tubes on ice for 30 min
28) Centrifuge at 4˚C for 15 min at 16,000 x g
29) Pipette out supernatant and discard (you can just decant)
30) Wash nucleic acid pellet with 500 uL ice cold 70% EtOH and gently vortex
a. Removes residual salt
31) Centrifuge at room temp for 2 min at 13,000 x g
32) Decant wash and dry pellet for 3 min
33) Dissolve the nucleic acid pellet in 450 uL of Tris (10 mM, pH 8) and transfer to a
deep well plate (DWP).
a. Its best to let samples set at 4˚C for a few hours or overnight. (I do this in the
tubes)
b. There may be a slight pellet so just mix gently and transfer to DWP. Mix with
pipette.
c. Verify samples match paper chart
d. Samples or DWP can be frozen until King Fisher step is done.
King Fisher Isolation
34) Add 0.5 volumes of XP2 buffer, 10 uL Mag-Bind Particles CND, and 5 uL Binding
Enhancer to DWP containing DWP. (I do this prior to putting samples in DWP.)
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a. The XP2 buffer, Mag-Bind Particles, and Binding Solution can be prepared in a
Master Mix.
i. 225 uL x 110 = 24,750 uL = 24.75 mL XP2 buffer
ii. 10 uL x 110 = 1100 uL = 1.1 mL Mag-Bind CND
iii. 5 uL x 110 = 550 uL Binding Enhancer
iv. Add 240 uL of this solution to each well of lysate plate
35) Add 300 uL XP2 buffer to a new DWP, 33 mL
36) Add 300 uL VHB buffer to a new DWP, 33 mL
37) Add 400 uL SPM Wash buffer to a new DWP, 44 mL
38) Add 400 uL SPM Wash buffer to a new DWP, 44 mL
39) Add 130 uL Elution buffer to a new DWP, 14.3 mL
40) Place plates on Kingfisher in correct areas when prompted by machine using protocol
Omega_noH2O
a. Takes 30 min
b. Make sure to have an additional sterile DWP and tip comb every time.
c. DWP for tip comb can be reused, just place silver tape on it
41) Save samples plate and elution plate and cover with silver tape and freeze.
42) Transfer 50 uL of elution into a 96 well plate for downstream analysis

PCR Primer Step
43) Thaw elution plate and bacterial primer plate on ice or in fridge. Make sure primer
plate number matches your plate number (1 for 1, 2 for 2, etc.)
44) Remove Terra Box from freezer to thaw.
PCR recipe
Recipe
1 rxn
100 rxn
Terra Buffer
12.5 uL
1250 uL = 1.25 mL
Terra Polymerase
0.5 uL
50 uL
Primer
1.0 uL
These are individual per well
H20
9.0 uL
900 uL = 0.9 mL
DNA
2.0 uL
200 uL
Total
25.0 uL
2500 uL = 2.5 mL
45) Spin elution and primer plates in centrifuge at 3000 rpm for 1 min
46) Add reagents to PCR plate
a. Master mix = Buffer + polymerase + H20 = 22 uL, can place in
b. Primer = 1 uL
c. DNA = 2 uL
d. Seal with a plate cover, make sure its well sealed
e. Spin PCR plate down.
47) Turn on PCR machine and place plate in holder
48) Use the “Illumina PCR 25c” protocol, 25 uL of total reaction
Stage
1
2
2
2
3
3
Step
1
1
2
3
1
2
Temp, ˚C
98
98
55
68
68
4
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Time,
m:ss
Repetition

3:00
x1

0:30

0:30
x25

0:45

∞

4:00
x1

49) When PCR is finished, spin down plate. Plate can be covered with silver tape and
frozen or proceed to agarose gel.
DNA Agarose Gel Electrophoresis
50) Make an 1.5% agarose gel with 2 50-well combs
a. 250 mL TBE buffer + 3.75 g agarose
b. Microwave carefully until agarose has dissolved, make sure to avoid boil over
c. Temper media, add 12.5 uL of ethidium bromide and mix
d. Prior to pouring into gel casting frame. Add combs.
e. Let gel polymerize for an hour
51) Spin down PCR plate at 3000 rpm for 1 min.
52) Add 5 uL of PCR product to PCR plate and 3 uL of Xylene loading dye to each well
53) Seal primer plate with silver tape and freeze for later use.
54) Spin down loading dye plate.
55) Remove 50 kb ladder from freezer
56) Remove gel from casting frame and place in running box with buffer, remove combs
and make sure buffer floods all wells.
57) Add ladder to the first well on each well set.
58) Use multichannel to load samples into wells.
59) Plug in apparatus to power source and run at 120 V, 75 ?amps, and 60-75 mins.
60) Remove gel from buffer and place in gel doc to image gel.
a. Take a picture and double check bands. Clear bands are good. Smearing is boo
bad.
Normalization Step
61) Make sure PCR Amplified plate is thawed and spun down.
62) Add 20 uL of sample to a 96 well Binding plate (brand name), do not put tips in
bottom of wells.
63) Cover and spin down.
64) Turn on epMotion robot.
a. 96 well plate and solutions come from Charm Biotech 96 PCR Purification and
Normalization kit
b. Place 96 well plate on area B1. (The spot that holds a plate.)
c. Place new tip boxes on A2 and B2.
d. Place cartridge containing buffers on C2.
i. Solutions will be added to epMotion 30 mL Reservoirs.
ii. Binding solution, leftmost spot, and minimum of 2.125 mL needed
iii. Washing buffer, next spot, minimum of 9.805 mL needed.
iv. Elution buffer, next spot, minimum of 2.125 mL needed.
v. Reservoir covers should be taken off and placed under the machine for
coverage.
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e. Empty used tip bin if not done already. Keep an eye on this to avoid having tips
get stuck on the robot pipette and causing problems.
f. Load “Normalizationnewkit50” protocol on computer.
i. Add 20 uL of binding solution to all wells.
ii. Incubate for 60 min.
iii. Dump out liquid and spin plate upside down on a paper towel for 1 min
at 3000 rpm. Place plate back in the robot.
iv. Add 50 uL of washing buffer, incubate 30 sec, repeat step iii. Put a new
rack of tips in A2.
v. Repeat step iv.
vi. Wait 2 min, add 20 uL of Elution buffer.
g. Click “Run” tab, check “HEPA” box, well volume should be 20 uL, make sure
buffers meet minimum quantity. Add more volume for column next to minimum.
h. Robot might not recognize tip boxes, make sure tips are there and ignore
warning. Robot will also complain solution cartridge, click “Ignore”
i. Door can lifted to halt robot at anytime, close to resume.
65) Cover plate, vortex for 30 sec, spin down.
Pooling Sample libraries
66) Use epMotion robot again. Select “pooling_10uL_VWRtips” protocol.
a. Protocol will take 10 uL from each well and pool it in the 1.5 mL tube.
67) Place a new box of tips in A2. Dump used tip bin.
68) Place Blunting cartridge in C2, add clean 1.5 mL tube to the A1 position (top left
corner)
69) Click “Run” tab. Check HEPA box, click through “Next” steps until start.
70) When finished, cover plate with silver tape and freeze. Label tube and freeze or
continue to purification step.
Purification of DNA library
71) Follow protocol for “PCR clean-up “ of NucleoSpin Gel and PCR Clean-up kit. Use
1:2 dilution.
a. Adjust DNA binding condition
For very small sample volumes < 30 uL adjust the volume of the reaction
mixture to 50-100 uL with water.
Mix 1 volume of sample with 2 volumes of Buffer NTI
960 uL of DNA + 1920 uL of Mix, Mix is 1:2, 640 NTI buffer + 1280
PCR H2O
b. Bind DNA
Place a Nucleospin Gel and PCR Clean-up Column into a Collection Tube
(2 mL) and load up to 700 uL sample.
Centrifuge for 30 s at 11,000 x g. Discard flow-through and place the
column back into the collection tube.
Load remaining sample if necessary and repeat the centrifugation step.
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c. Add 700 uL Buffer NT3 to the NucleoSpin Gel and PCR Clean-up Column.
Centrifuge for 30 s at 11,000 x g. Discard flow-through and place the column
back into the collection tube.
Repeat previous washing step to minimize chaotropic salt carry-over and
improve A260/A230 values.
d. Dry silica membrane
Centrifigure for 1 min at 11,000 x g to remove Buffer NT3 completely.
Make sure the spin column does not come in contact with the flowthrough while removing it from the centrifuge and the collection tube.
e. Elute DNA
Place the Nucleospin Gel nad PCR Clean-up Column into a new 1.5 mL
microcentrifuge tube. Add 15-30 uL Buffer NE and incubate at room
temperature (18-25℃) for 1 min. Centrifuge for 1 min at 11,000 x g.
72) Label tube with plate number and freeze.
Quantification of DNA library
73) Use DeNovix kit and reader. You must use DeNovix tubes for procedure.
74) Making working solution (WS)
a. Make sure buffer and dye are at room temp when used. You can take an aliquot
of the buffer so you don’t have to get the whole bottle to temp.
b. 200 uL buffer + 2.0 uL dye for each library and standard. Add an extra 0.5 to
provide room for pipetting error. (2 standards + 4 library + 0.5 extra = 6.5
libraries)
c. 200 uL buffer x 6.5 = 1300 uL buffer, 2.0 uL dye x 6.5 = 13.0 uL dye
75) Add working solution to tubes labeled for standards and samples.
a. Standards need to be made each day for quantification.
b. Don’t add standard or sample library until ready to proceed.
c. 190 uL WS + 10 uL of 0 standard
d. 190 uL WS + 10 uL of 25 standard
e. 199 uL WS + 1 uL sample library (Make one for each sample library)
76) Follow procedure for standards and samples, one at a time:
a. Launch Fluoro dsDNA app using DeNovix fluorometer.
b. Use drop down menu to select “DeNovix dsDNA Ultra High Sensitivity
Assay”
c. Select “Preconfigured 2 standards” and then choose “Generate New Standard
Curve”
d. Add 0 standard to tube.
e. Spin briefly on mini centrifuge to ensure samples are mixed together.
f. Time for 5 min
g. Place tube in Fluorometer slot and close lid, tap “Measure” to measure.
h. Add 25 standard to tube and repeat steps e, f, and g.
i. After both standards have been run, tap the “Samples” button.
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j. Add sample library DNA to respective tube and repeat steps e, f, and g. Write
down concentration.
k. Repeat until all libraries have been run.
77) Enter concentrations into Excel file “Library Dillution Calculator Illumina”. This will
convert pg/mL to nM.
78) Determine dilutions needed to created 4 nM libraries for pooling. (Need to add to this
once I have hit this step.
a. C1V1=C2V2
Aligent High Sensitivity DNA Kit Quick Start Guide For Bioanalyzer Chip
Preparing the Gel-Dye Mix
1. Allow high sensitivity DNA dye concentrate (blue) and high sensitivity DNA gel
matrix (red) to equilibrate to room temperature for 30 min.
2. Add 15 uL of high sensitivity DNA dye concentrate (blue) to a high sensitivity
DNA gel matrix vial (red).
3. Vortex solution well and spin down. Transfer to spin filter.
4. Centrifuge at 2240 g +/- 20% for 10 min. Protect solution from light. Store at 4℃.
Use prepared gel-dye mix within 6 weeks of preparation
Loading the Gel-Dye Mix
1. Allow the gel-dye mix to equilibrate to room temperature for 30 min before use.
2. Put a new high sensitivity DNA chip on the chip priming station.
3. Pipette 9 uL of gel-dye mix in the well marked G with white lettering and a black
circle around it.
4. Make sure that the plunger is positioned at 1 mL and then close the chip priming
station.
5. Press plunger until it is held by the clip.
6. Wait for exactly 60 s then release clip.
7. Wait for 5 s, then slowly pull back the plunger to the 1 mL position.
8. Open the c hip priming station and pipette 9 uL of gel-dye mix in the wells
marked G with black lettering, white surrounding.
Loading the Marker
1. Pipette 5 uL of marker (green) in all sample and ladder wells. Do not leave any
wells empty.
Loading the Ladder and Samples
1. Pipette 1 uL of high sensitivity DNA ladder (yellow) in the well marked with a
ladder.
2. In each of the 11 sample wells pipette 1 uL of sample (used wells) or 1 uL of
marker (unused wells).
3. Put the chip horizontally in the adapter and vortex for 1 min at the indicated
setting (2400 rpm).
4. Run the chip in the Agilent 2100 Bioanalyzer instrument within 5 min.

Sodium Acetate and Ethanol DNA Library Precipitation
1. Add 1/10 volume sodium acetate (3M, pH=5.2).
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2. Add 2.5X volume (calculated after addition of sodium acetate) of at least 100%
isopropanol.
3. Add 1.0 uL Carrier RNA from Qiagen kit to tube.
4. Incubate at -80℃ overnight.
5. Centrifuge at >14,000 x g for 30 min at room temperature to 4℃.
6. Discard supernatant carefully, making sure the DNA pellet (may not be visible) is
not discarded.
7. Rinse with cold 50 uL 70% EtOH.
8. Centrifuge for 15 min at 4℃.
9. Discard supernatant and dissolve pellet in TE or EB. Make sure buffer comes in
contact with the whole surface of the tube since a significant portion of DNA may
be deposited in the walls instead of in the pellet.
*** Don’t resuspend pellet until sequencing, trying to minimize library
concentrate degradation.
BluePippin Purification Protocol – 1.5% Agarose Gel Cassette
1. Prepare DNA samples
a. Bring DNA sample up to 30 uL with TE.
b. Bring loading solution to room temperature.
c. For each sample, combine 30 uL of DNA sample with 10 uL of leading
solution/marker mix (labeled K).
d. Mix samples thoroughly (vortex mixer). Brieflky centrifuge to collect.
2. Program a Protocol
a. In the Pippin Prep Software, go to the Protocol Editor Tab.
b. Click “Cassette” folder, and select “1.5% DF Marker K”.
c. Select the collection mode for each lane (usually “Tight” or “Range”_, and
enter the size selection parameters.
d. Click the “Use Internal Standards” button.
e. Make sure the “Ref Lane” values match the lane numbers.
f. Press “Save As” and name and save the protocol.
3. Calibrate the Optics with the Calibration Fixture
a. Place the calibration fixture onto the optical nest. Close the lid.
b. Press “CALIBRATE” to launch the calibration window.
c. Enter 0.80 in the “Target I ph, mA” field. Press “CALIBRATE” boutton
in the window, and when complete press “EXIT”.
4. Inspect the Gel Cassette
a. Remove the cassette from the foil packaging.
b. Inspect the levels of buffer in all buffer reservoirs. Reservoirs should be
nearly full. If the buffer level in any reservoir appears less than 50% full,
fill with spare buffer.
c. Inspect the gel columns. Look for obvious breakage of the agarose column
in each channel. If there is obvious breakage, do not use the lane.
Remaining lanes can be used.
d. Inspect for bubbles due to separation of agarose from bottom of cassette in
the region used for optical detection of DNA. If a bubble is observed, do
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not use the lane. A bubble on the top of the gel column will not affect
detection.
5. Prepare the Cassette for Loading
a. Dislodge bubbles from behind the elution wells. Tilt the cassette sample
well side down, to release the any trapped bubbles behind the elution
modules.
b. Place Cassette into the optical nest. Keep the cassette slightly tilted down
so that the bubbles in the elution reservoirs don’t return to the area behind
the elution modules. Be sure the cassette is fully seated into the bottom of
the nest to ensure proper optical alignment.
c. Remove the white tabbed adhesive strips from the cassette. Place one hand
on the cassette, and hold it firmly in the nest. Grab the white tabs of the
tape and pull the strips firmly and slowly toward the front of the
BluePippin until they are removed.
d. Remove buffer from all elution modules and replace with 40 uL of fresh
electrophoresis buffer. Make sure that the pipette tips extend all the way to
the bottom of the elution modules without sealing the elution port opening.
Test tip fit using the empty rinse cassette supplied with the instrument.
e. Seal the elution wells with the adhesive tape strips. Tape for sealing the
elution wells are supplied with cassette packaging. Place tape over the
elution wells and rub firmly to fix the tape in position.
f. Check the buffer level in the sample wells. Immediately prior to loading,
sample wells should be completely filled to the top with buffer. If any
wells are underfilled, top them with additional buffer.
g. Perform the continuity test. Close the lid and press the “Test” button
located in the lower right area of the Main screen. The test routine runs
automatically and measures the current in each separation and elution
channel. And should return a “PASS” for each separation and elution
channel. The cassette temperature must be above 17℃(62℉).
6. Load Samples
a. Re-check the buffer level in the sample wells. Make sure that sample wells
are completely full to the top with electrophoresis buffer. Fill with
additional buffer, if necessary.
b. Remove 40 uL of buffer from the first sample well, and load 40 uL of
sample into that well. Take care to not pierce the agarose with the pipette
tip. There is gel on all sides and bottom of the sample well. In addition,
there is an agarose “chimney” surrounding the top of the sample well that
protrudes up through the cassette cover. When removing buffer, some
users find it useful to immerse the pipette tip just below the surface of the
buffer and follow the liquid level down with the tip as the buffer is
removed. When buffer removal is completed, there will be ~30 uL of
buffer left in the well. When adding sample, place tip of pipette just below
the surface of the buffer, and follow the liquid level up with the tip as the
well fills. Don’t be concerned if the sample well slightly overfills. The

130
density of the sample will allow it to sink before it can flow out of the
well.
c. Repeat step b for the remaining four wells.
7. Run
a. Close the lid, go to the Main Tab, and make sure the proper protocol is
loaded in the “Protocol Name” field.
b. Press “START”. The run will automatically stop when every collection is
complete.
8. Collect Fractions
a. Remove sampels using a standard 100-200 uL pipette. Samples will be in
a Tris-TAPS buffer at a volume of 40 uL. Samples should be suitable for
amplification. Do not let samples remain in cassette overnight.
b. Remove cassette and dispose of properly. Do not keep used cassettes in
the Pippin with the cover closed. Humidity from the cassette may cause
damage to electrodes.
NextSeq System Denature and Dilute Libraries Guide
1. Denature Libraries
a. Combine 5 uL of DNA library and 5 uL 0.2 N NaOH in a microcentrifuge
tube.
b. Vortex briefly and then centrifuge at 280 x g for 1 minute.
c. Incubate at room temperature for 5 minutes.
d. Add the following volume of 200 mM Tris-HCl, pH 7.
e. Vortex briefly and then centrifuge at 280 x g for 1 minute.
2. Dilute Denatured Libraries to 20 pM.
a. Add the following volume of prechilled HT1 to the tube of denatured
libraries.
i. 985 uL for 4 nM
ii. The result is a 20 pM denatured library.
b. Vortex briefly and then centrifuge at 280 x g for 1 minute.
c. Place the 20 pM libraries on ice until you are ready to proceed to final
dilution.
Speed-Vacuum DNA Concentration
1. Using Denovix kit, determine concentration of DNA present in elution buffer
and how much elution buffer needed to achieve optimal concentration.
2. Place microcentrifuge tube containing library in Speed-Vacuum with tube cap
open and a balance and close the lid.
3. Turn on centrifuge portion of vacuum followed by the vacuum pump.
4. Monitor amount of fluid present in library until desired concentration is
achieved.
5. Shut off vacuum and centrifuge.
6. Check concentration with Denovix again.
MiSeq Library Preparation and Sequencing
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1. Remove a 500 cycle reagent cartridge from the -20 ℃ freezer. Place in room
temperature water bath for one hour. Place HT1 buffer tube in 4 ℃ fridge.
2. Copy sample sheet to sample sheet folder on MiSeq. Rename sample sheet to
match barcode of reagent cartridge.
3. When the reagent cartridge has thawed, dry bottom with paper towel. Invert
the cartridge repeatedly to check each well is thawed. This also served to mix
the reagents. Place in hood.
4. Thaw library, PhiX, and sequencing primers. Check to make sure HT1 is
thawed.
5. Place 3 uL of the Read 1 Sequencing Primer(s) into a clean PCR tube. Repeat
in separate tubes for the Index Primer(s) and Read 2 Sequencing Primer(s).
6. Using a 1000 uL pipette tip, break the foil over wells 12, 13, 14, and 17.
7. Use an extra long 100 uL tip with the pipettor set on 75 uL to transfer the 3 uL
of Read 1 Sequencing Primer to the bottom of well 12 and pipette 10X to mix.
Repeat this process spiling the Index primer into well 13 and the Read 2
Sequencing Primer into well 14.
8. Prepare a fresh dilution of 0.2N NaOH.
9. To a 1.5 mL tube add 10 uL of library, and 10 uL of 0.2N NaOH. To a
separate tube add 2 uL PhiX, 3 uL PCR grade water, and 5 uL of 0.2N NaOH.
Vortex both tubes to mix and spin for 1 minute at 400rcf.
10. Allow the tubes to incubate at room temperature for 5 minutes. Immediately
add 980 uL of HT1 to library tube and 990 uL HT1 to the PhiX tube.
11. Use HT1 to dilute both the library and PhiX to 10pM. For a 5% PhiX run,
combine 950 uL of 3.5pM Library and 50 uL PhiX in a final tube. Vortex.
Load 600 uL of this solution into well 18 on the reagent cartridge. See
example below:
a. (1.45 nM library x 10 uL) + (0.2N NaOH x 10 uL) + 980 uL HT1 =
14.5 pM Lib, 0.002N NaOH
b. (14.5pM lib x 241.38 uL + 758.62 uL HT1 = 3.5pM lib, 0.00048N
NaOH
c. [(10nM PhiX x 2 uL) + 3 uL H2O] + (0.2N NaOH x 5 uL) + 990 uL
HT2 = 20pM PhiX, 0.001 NaOH
d. (20pM PhiX x 175 uL) + 825 uL HT1 = 3.5 PhiX, 0.0000175N NaOH
e. (3.5pM Lib x 950 uL) + (3.5M PhiX x 50 uL) = solution loaded
f. Solution loaded is 3.5pM overall with a 3.325 pM library
concentration, 0.175 PhiX concentration, and 0.0000457N NaOH
12. Set reagent cartridge aside. Unbox flow cell and PR2 bottle.
13. Thoroughly rinse the flow cell with Milli-Q water. Carefully dry by blotting
with lint free wipes. Give special attention to the edges and points of
intersection between the glass and plastic.
14. We a new wipe with 100% alcohol and wipe the glass on both sides avoiding
the rubber intake ports.
15. Visually inspect the flow cell to ensure there are no blemishes, particles, or
fibers on the glass.
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16. Follow the screen instructions and load the flow cell, reagent cartridge, and
PR2 bottle. Empty and replace the waste bottle.
17. Ensure the machine recognizes the correct sample sheet and the run
parameters are correct.
18. Wait for the MiSeq to perform its pre-run check, and press start.

